AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaInformation ScienceHealth Care
CystadenocarcinomaCystadenocarcinoma, MucinousCystadenomaCystadenocarcinoma, PapillaryCystadenocarcinoma, SerousCystadenoma, MucinousAppendiceal NeoplasmsMucoceleCystsPyonephrosisMixed Tumor, MesodermalOvarian NeoplasmsBiliary Tract NeoplasmsCystadenoma, PapillaryParotid NeoplasmsBarium SulfatePseudomyxoma PeritoneiBile Ducts, IntrahepaticBile Duct NeoplasmsRetroperitoneal NeoplasmsPancreatic NeoplasmsTomography, X-Ray ComputedSalivary Gland NeoplasmsPancreatectomyHydroxy AcidsPancreaticoduodenectomyEncyclopedias as TopicAbdomen, AcuteCystadenoma, SerousRetroperitoneal SpaceAdenomaFallopian Tube NeoplasmsSecond-Look SurgeryPeritoneal NeoplasmsCarcinoma, EndometrioidEpididymal Secretory ProteinsCA-125 AntigenDigestive System AbnormalitiesTeratomaNeoplasmsFishesAntineoplastic AgentsPrimary MyelofibrosisSplenomegalyBreastStomach NeoplasmsAccess to InformationPeriodicals as TopicJournal Impact FactorCell AdhesionPeer Review, ResearchPublishingBacterial Translocation
Cystadenocarcinoma
A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed)
Cystadenocarcinoma, Mucinous
A malignant cystic or semisolid tumor most often occurring in the ovary. Rarely, one is solid. This tumor may develop from a mucinous cystadenoma, or it may be malignant at the onset. The cysts are lined with tall columnar epithelial cells; in others, the epithelium consists of many layers of cells that have lost normal structure entirely. In the more undifferentiated tumors, one may see sheets and nests of tumor cells that have very little resemblance to the parent structure. (Hughes, Obstetric-Gynecologic Terminology, 1972, p184)
Cystadenoma
A benign neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. In some instances, considerable portions of the neoplasm, or even the entire mass, may be cystic. (Stedman, 25th ed)
Cystadenocarcinoma, Papillary
An adenocarcinoma in which the tumor elements are arranged as finger-like processes or as a solid spherical nodule projecting from an epithelial surface.
Cystadenocarcinoma, Serous
A malignant cystic or semicystic neoplasm. It often occurs in the ovary and usually bilaterally. The external surface is usually covered with papillary excrescences. Microscopically, the papillary patterns are predominantly epithelial overgrowths with differentiated and undifferentiated papillary serous cystadenocarcinoma cells. Psammoma bodies may be present. The tumor generally adheres to surrounding structures and produces ascites. (From Hughes, Obstetric-Gynecologic Terminology, 1972, p185)
Cystadenoma, Mucinous
A multilocular tumor with mucin secreting epithelium. They are most often found in the ovary, but are also found in the pancreas, appendix, and rarely, retroperitoneal and in the urinary bladder. They are considered to have low-grade malignant potential.
Appendiceal Neoplasms
Tumors or cancer of the APPENDIX.
Mucocele
A retention cyst of the salivary gland, lacrimal sac, paranasal sinuses, appendix, or gallbladder. (Stedman, 26th ed)
Cysts
Any fluid-filled closed cavity or sac that is lined by an EPITHELIUM. Cysts can be of normal, abnormal, non-neoplastic, or neoplastic tissues.
Pyonephrosis
Distention of KIDNEY with the presence of PUS and suppurative destruction of the renal parenchyma. It is often associated with renal obstruction and can lead to total or nearly total loss of renal function.
Mixed Tumor, Mesodermal
A sarcoma of the body of the uterus arising in older women, composed of more than one mesenchymal tissue, especially including striated muscle cells. It is associated with previous pelvic radiation exposure in 20% of patients. (Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1702)
Ovarian Neoplasms
Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
Biliary Tract Neoplasms
Tumors or cancer in the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.
Cystadenoma, Papillary
A benign neoplasm of the ovary.
Parotid Neoplasms
Tumors or cancer of the PAROTID GLAND.
Barium Sulfate
A compound used as an x-ray contrast medium that occurs in nature as the mineral barite. It is also used in various manufacturing applications and mixed into heavy concrete to serve as a radiation shield.
Pseudomyxoma Peritonei
A condition characterized by poorly-circumscribed gelatinous masses filled with malignant mucin-secreting cells. Forty-five percent of pseudomyxomas arise from the ovary, usually in a mucinous cystadenocarcinoma (CYSTADENOCARCINOMA, MUCINOUS), which has prognostic significance. Pseudomyxoma peritonei must be differentiated from mucinous spillage into the peritoneum by a benign mucocele of the appendix. (Segen, Dictionary of Modern Medicine, 1992)
Bile Ducts, Intrahepatic
Passages within the liver for the conveyance of bile. Includes right and left hepatic ducts even though these may join outside the liver to form the common hepatic duct.
Bile Duct Neoplasms
Tumors or cancer of the BILE DUCTS.
Retroperitoneal Neoplasms
Pancreatic Neoplasms
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
Tomography, X-Ray Computed
Tomography using x-ray transmission and a computer algorithm to reconstruct the image.
Salivary Gland Neoplasms
Tumors or cancer of the SALIVARY GLANDS.
Pancreatectomy
Surgical removal of the pancreas. (Dorland, 28th ed)
Hydroxy Acids
Organic compounds containing both the hydroxyl and carboxyl radicals.
Pancreaticoduodenectomy
The excision of the head of the pancreas and the encircling loop of the duodenum to which it is connected.
Encyclopedias as Topic
Works containing information articles on subjects in every field of knowledge, usually arranged in alphabetical order, or a similar work limited to a special field or subject. (From The ALA Glossary of Library and Information Science, 1983)
Abdomen, Acute
A clinical syndrome with acute abdominal pain that is severe, localized, and rapid in onset. Acute abdomen may be caused by a variety of disorders, injuries, or diseases.
Cystadenoma, Serous
A cystic tumor of the ovary, containing thin, clear, yellow serous fluid and varying amounts of solid tissue, with a malignant potential several times greater than that of mucinous cystadenoma (CYSTADENOMA, MUCINOUS). It can be unilocular, parvilocular, or multilocular. It is often bilateral and papillary. The cysts may vary greatly in size. (Dorland, 27th ed; from Hughes, Obstetric-Gynecologic Terminology, 1972)
Retroperitoneal Space
An area occupying the most posterior aspect of the ABDOMINAL CAVITY. It is bounded laterally by the borders of the quadratus lumborum muscles and extends from the DIAPHRAGM to the brim of the true PELVIS, where it continues as the pelvic extraperitoneal space.
Adenoma
A benign epithelial tumor with a glandular organization.
Fallopian Tube Neoplasms
Benign or malignant neoplasms of the FALLOPIAN TUBES. They are uncommon. If they develop, they may be located in the wall or within the lumen as a growth attached to the wall by a stalk.
Second-Look Surgery
A followup operation to examine the outcome of the previous surgery and other treatments, such as chemotherapy or radiation therapy.
Peritoneal Neoplasms
Tumors or cancer of the PERITONEUM.
Carcinoma, Endometrioid
An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.
Epididymal Secretory Proteins
Proteins secreted by the epididymal epithelium. These proteins are both tissue- and species-specific. They are important molecular agents in the process of sperm maturation.
CA-125 Antigen
Carbohydrate antigen most commonly seen in tumors of the ovary and occasionally seen in breast, kidney, and gastrointestinal tract tumors and normal tissue. CA 125 is clearly tumor-associated but not tumor-specific.
Digestive System Abnormalities
Congenital structural abnormalities of the DIGESTIVE SYSTEM.
Teratoma
A true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. It is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. They are classified histologically as mature (benign) or immature (malignant). (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1642)
Neoplasms
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Fishes
A group of cold-blooded, aquatic vertebrates having gills, fins, a cartilaginous or bony endoskeleton, and elongated bodies covered with scales.
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS.
Primary Myelofibrosis
A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone.
Splenomegaly
Enlargement of the spleen.
Breast
In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.
Stomach Neoplasms
Tumors or cancer of the STOMACH.
Access to Information
Individual's rights to obtain and use information collected or generated by others.
Periodicals as Topic
A publication issued at stated, more or less regular, intervals.
Journal Impact Factor
A quantitative measure of the frequency on average with which articles in a journal have been cited in a given period of time.
Cell Adhesion
Adherence of cells to surfaces or to other cells.
Peer Review, Research
The evaluation by experts of the quality and pertinence of research or research proposals of other experts in the same field. Peer review is used by editors in deciding which submissions warrant publication, by granting agencies to determine which proposals should be funded, and by academic institutions in tenure decisions.
Publishing
"The business or profession of the commercial production and issuance of literature" (Webster's 3d). It includes the publisher, publication processes, editing and editors. Production may be by conventional printing methods or by electronic publishing.
Bacterial Translocation
The passage of viable bacteria from the GASTROINTESTINAL TRACT to extra-intestinal sites, such as the mesenteric lymph node complex, liver, spleen, kidney, and blood. Factors that promote bacterial translocation include overgrowth with gram-negative enteric bacilli, impaired host immune defenses, and injury to the INTESTINAL MUCOSA resulting in increased intestinal permeability. Bacterial translocation from the lung to the circulation is also possible and sometimes accompanies MECHANICAL VENTILATION.

Borderline ovarian tumours in Vaud, Switzerland: incidence, survival and second neoplasms. (1/75)

Between 1976 and 1996, 176 borderline ovarian tumours were registered in the Cancer Registry of the Swiss canton of Vaud, corresponding to an age-adjusted incidence (world standard) of 2.7 in 100,000. Incidence rose from 1.7 per 100,000 during 1976-81 to 2.7 per 100,000 during 1987-91, and then levelled off; 58% of cases were serous and 41% mucinous. Relative survival was 94% at 10 years; 18 second neoplasms were observed, compared with 10.3 expected, and there was a significant excess of invasive ovarian cancers (four observed, including three synchronous, compared with 0.4 expected).  (+info)

Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms? (2/75)

OBJECTIVE: To determine whether the long-term behavior of cystic mucinous neoplasms of the pancreas could be predicted using a novel, precisely defined classification of benign mucinous cystadenomas, noninvasive proliferative cystic mucinous neoplasms, and invasive mucinous cystadenocarcinomas. The primary interest was to obtain long-term follow-up after complete resection to determine the recurrence rates based on this objective classification. BACKGROUND: Current understanding is that all cystic mucinous neoplasms of the pancreas are potentially malignant and that mucinous cystadenomas, when completely removed, are biologically benign. Cystadenocarcinomas are thought to be less aggressively malignant than ordinary ductal adenocarcinoma, but reported recurrence rates vary widely and are unpredictable. METHODS: All patients who underwent "curative" resection for cystic mucinous neoplasms at Mayo Clinic Rochester from 1940 to 1997 were identified. All available pathology slides, gross specimens, and clinical records were reviewed, eliminating patients with inadequate documentation. Neoplasms were reclassified as mucinous cystadenomas, noninvasive proliferative mucinous cystic neoplasms, or invasive cystadenocarcinomas based on specific histologic criteria. RESULTS: Of 84 patients (70 women, 14 men) with cystic mucinous neoplasms of the pancreas, 54 were classified as cystadenomas, 23 as noninvasive proliferative cystic mucinous neoplasms, and only 7 as cystadenocarcinomas. Recurrent disease developed in none of the 77 patients without invasion, but 5 of the 6 patients surviving resection for cystadenocarcinomas died of recurrent cystadenocarcinoma within 5 years. CONCLUSIONS: When the neoplasm is completely resected and subjected to adequate histopathologic examination based on these objective criteria, absence of tissue invasion predicts a curative operation and detailed follow-up may be unnecessary. In contrast, a histologic diagnosis of invasive cystadenocarcinoma portends a dismal prognosis, similar to that of typical ductal adenocarcinoma of the pancreas.  (+info)

Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers. (3/75)

Allelic deletions of multiple chromosome 17q loci in sporadic ovarian cancer of epithelial origin suggest that inactivation of tumor suppressor gene(s) in these regions may be important for ovarian tumorigenesis. To further define the pattern of allelic imbalance in epithelial ovarian tumors of different histologies, a PCR-based assay was used to assess loss of heterozygosity (LOH) of polymorphic markers representative of TP53, BRCA1, NME1 and GH1, and region 17q23-25. LOH was observed for at least one marker in 68% of malignant tumors (n=60) and in 18% tumors of borderline malignancy (n=11), but not in benign tumors (n=5). The highest frequency of LOH in malignant tumors (64%) was observed with D17S801 on 17q25. Ten of 39 malignant ovarian tumors displaying LOH of at least one 17q marker, displayed a LOH pattern enabling the determination of a minimal region of overlapping deletion defined by D17S795 and D17S801. One borderline tumor also displayed an interstitial LOH pattern that overlapped this 17q25 minimal region of deletion. The histologies of malignant tumors displaying a pattern indicative of interstitial 17q deletions were of the endometrioid, clear cell and mucinous epithelial types. As the minimal region of overlap defined by these tumors overlap regions deleted in malignant tumors of all histologic types, and in a tumor of borderline malignancy, the 17q25-tumor suppressor may be implicated in the development of all types of epithelial ovarian tumors.  (+info)

Overexpression and localization of heat shock proteins mRNA in pancreatic carcinoma. (4/75)

In the present study we examined the localization and overexpression of heat shock proteins (hsps), mainly hsp90, in pancreatic carcinoma tissue compared with control tissue (including chronic pancreatitis and normal pancreas tissue), with the aid of immunohistochemical staining, in situ hybridization and reverse transcriptase polymerase chain reaction. Hsp90 alpha mRNA was overexpressed more highly in pancreatic carcinoma than in the control tissue. The proliferating-cell-nuclear-antigen labeling index was also high in pancreatic carcinoma tissue compared with the other tissue. These findings suggest that the overexpression of hsp90 alpha mRNA in carcinomas may be correlated with cell proliferation. However, hsp90 beta was constitutively overexpressed almost equally in all groups of pancreatic tissue including pancreatic carcinoma, chronic pancreatitis and normal pancreas tissue. Immunohistochemical staining demonstrated a differentiation in the expression of hsp90 between histological types of pancreatic carcinoma. These findings suggest that hsp90 alpha is involved in carcinogenesis and that hsp90 beta is correlated to structural conformation. Hsp90 alpha and hsp90 beta seem to perform different functions in tissue containing malignant cells. P53, MDM2 and WAF1, that were cell-cycle-related oncogene product were more strongly expressed in the nuclei of the cancer cells of the cancer tissue. Especially, MDM2 was more strongly expressed in mucinous carcinoma and the mucin secreting tissues surrounding pancreatic carcinoma tissue. The expression of MDM2 protein might also be correlated to secretion systems during structural conformation and be correlated to hsp90 beta.  (+info)

P73 gene expression in ovarian cancer tissues and cell lines. (5/75)

Thep73 gene, a homology of p53, is a new candidate of imprinting and tumor suppressor gene. To investigate the role of p73 in ovarian cancer, we studied the allelic expression in 56 cases of ovarian cancer using StyI polymorphism analysis. We also examined p73 expression by semi-quantitative reverse transcription-PCR as well as by Western blot analysis and DNA methylation study of the CpG island in exon 1 in ovarian cancer tissues and cell lines. Loss of heterozygosity was found in 8.3% (2 of 24) of the cases. Biallelic expression was demonstrated in 91.7% (22 of 24) of the tumor samples, in 70.8% (17 of 24) of the normal samples, and in 1 ovarian cancer cell line. Imbalanced expression and monoallelic expression were found in three and two pairs of matched samples, respectively. Overexpression of p73 was found in advanced ovarian cancer rather than in early-stage disease or in borderline ovarian tumor. No significant difference was found in the p53 expression. Three cell lines with absent p73 protein expression and one tumor sample with monoallelic expression were methylated in the CpG island. Demethylation in SKOV3 cell line using 5-azacytidine can reactivate the expression of this gene in both the mRNA and the protein level. Our results indicated that p73 was not imprinted in most of the ovarian cancer and normal tissues, but it could be involved in the advanced ovarian cancer through overexpression. DNA methylation may contribute to the lack of p73 expression.  (+info)

The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation. (6/75)

Proteolysis mediated by matrix metalloproteinases (MMPs) and serine proteinases is associated with cancer invasion and metastasis. Activation of latent proMMPs, and especially the proforms of the type IV collagen degrading gelatinases A and B (proMMP-2 and proMMP-9), is thought to be a critical step in this process. We have recently found that human tumour-associated trypsin-2 is a potent activator of proMMP-9 and it also activates proMMP-2 in vitro. Trypsinogen, MMP-2, and MMP-9 are expressed in ovarian cancer. To elucidate the function of trypsin in vivo, we studied whether high concentrations of trypsinogen-1, trypsinogen-2, their alpha(1)-proteinase inhibitor (API) complexes, and tumour-associated trypsin inhibitor (TATI) are associated with proMMP-2 and proMMP-9 activation in ovarian tumour cyst fluids. Zymography and immunofluorometric analysis of 61 cyst fluids showed a significant association between high trypsin concentrations and the activation of MMP-9 (P = 0.003-0.05). In contrast, the trypsin concentrations were inversely associated with the activation of MMP-2 (P = 0.01-0.02). Immunohistochemical analysis of ovarian tumour tissue demonstrated expression of trypsinogen-2 and TATI in the secretory epithelium. MMP-2 was detected both in stromal and epithelial cells whereas MMP-9 was detected in neutrophils and macrophage-like cells in stromal and epithelial areas. These results suggest that trypsin may play a role in the regulation of the MMP-dependent proteolysis associated with invasion and metastasis of ovarian cancer.  (+info)

Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. (7/75)

This study investigates whether and to what extent cyclooxygenase type-2 (COX-2) and inducible nitric oxide-synthase (iNOS), both known to have an immunosuppressive effect, are expressed in human ovarian tumors. Because COX-2 and iNOS can be expressed by activated macrophages, the presence of tumor-associated macrophages and the expression of COX-2 and iNOS by these tumor-associated macrophages were determined. The results obtained may provide insight into the function of COX-2 and iNOS expression by tumors. The expression of COX-2 and iNOS in tumor cells and macrophages was assessed in 18 malignant, 15 borderline, and 14 benign human ovarian tumors by immunohistochemical staining of frozen tissue sections. The intra- and peritumoral macrophages were stained using an anti-CD68 monoclonal antibody. Most of the malignant tumors (15 of 18), 10 of 15 borderline, and 9 of 14 benign tumors showed COX-2 expression in the epithelial cells, a result which indicates that COX-2 expression is not exclusive to malignancy. In addition, COX-2 staining was more intense in the epithelial cells of benign and borderline tumors than in malignant tumors. Weak iNOS staining was observed in 5 of 18 malignant, 4 of 15 borderline, and 5 of 14 benign tumors. The number of tumor-associated macrophages varied widely between the different tumors. The highest number of tumor-associated macrophages (> or =20/0.125 mm(2)) was observed in malignant tumors, whereas low to moderate intra- and peritumoral macrophage infiltration (5-20/0.125 mm(2)) was observed in the borderline and benign tumors. COX-2-positive tumor-associated macrophages were found in 3 of 18 malignant tumors, 7 of 15 borderline tumors, and 1 of 14 benign tumors. The number of COX-2-positive tumor-associated macrophages ranged from 3 to 30% of the total macrophage population. Some malignant (4 of 18), borderline (5 of 15), and benign (2 of 14) tumors contained iNOS-positive macrophages. Notable was that COX-2- and iNOS-positive macrophages were predominantly located in the tumor stroma, the regions between tumor and stroma, and in the lumina of the tumor when located in the tumor tissue. These data indicate that not only malignant but also borderline and benign ovarian tumors can exhibit increased levels of COX-2 and iNOS expression. In addition, a small proportion of the tumor-associated macrophages found in malignant, borderline, and benign tumors seems to be in an activated state, judged by their iNOS and COX-2 expression. This subpopulation of tumor-associated macrophages was invariably located in the tumor stroma or in the lumina of the tumor, specifically suggesting that macrophages outside the tumor can be tumor cytotoxic.  (+info)

Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. (8/75)

Recently, some studies have shown that delayed scanning with (18)F-FDG PET may help to differentiate malignant from benign pancreatic lesions. However, no study has evaluated the relationship between temporal changes in (18)F-FDG uptake and expression of hexokinase or glucose transporter. METHODS: Twenty-one consecutive patients with pancreatic cancer were studied preoperatively by dual-phase (18)F-FDG PET, performed 1 and 2 h after injection of (18)F-FDG. The standardized uptake value (SUV) of the pancreatic cancer was determined, and the retention index (RI) (%) was calculated by subtracting the SUV at 1 h (SUV1) from the SUV at 2 h (SUV2) and dividing by SUV1. The percentages of cells strongly expressing hexokinase type-II (HK-II) and glucose transporter-1 (GLUT-1) were scored on a 5-point scale (1 = 0%-20%, 2 = 20%-40%, 3 = 40%-60%, 4 = 60%-80%, 5 = 80%-100%) by visual analysis of immunohistochemical staining of paraffin sections from the tumor specimens using anti-HK-II and anti-GLUT-1 antibody (HK-index and G-index, respectively). RESULTS: SUV2 (mean +/- SD, 5.7 +/- 2.6) was higher than SUV1 (5.1 +/- 2.1), with an RI of 8.5 +/- 11.0. Four cases of cancer, in which SUV2 showed a decline from SUV1, showed a low HK-index (1.8 +/- 1.1), whereas 4 cases with an RI of > or =20 and 13 cases with an intermediate RI (0-20) showed significantly higher HK-indices (4.3 +/- 0.7 and 3.1 +/- 1.5, respectively; P < 0.05). RI showed a positive correlation with HK-index, with an R(2) of 0.27 (P < 0.05), but no significant correlation with the G-index. SUV1 showed no relationship with the HK-index but showed a weak positive correlation with the G-index, with an R(2) of 0.05 (P = 0.055). CONCLUSION: These preliminary findings suggest that the RI obtained from dual-phase (18)F-FDG PET can predict HK-II expression and that the SUV (at 1 h) has a positive correlation with GLUT-1 expression but not with HK-II expression.  (+info)

Clinical Evidence for Adenoma-Carcinoma Sequence in Primary Retroperitoneal Mucinous CystadenocarcinomaClinical Evidence for Adenoma-Carcinoma Sequence in Primary Retroperitoneal Mucinous Cystadenocarcinoma
Clinical Evidence for Adenoma-Carcinoma Sequence in Primary Retroperitoneal Mucinous Cystadenocarcinoma. PubMed, SCI, Scopus, ESCI, PMC indexed
https://fortunejournals.com/articles/clinical-evidence-for-adenomacarcinoma-sequence-in-primary-retroperitoneal-mucinous-cystadenocarcinoma.html
Mucinous cystadenocarcinoma - WikipediaMucinous cystadenocarcinoma - Wikipedia
Mucinous cystadenocarcinoma is a type of tumor in the cystadenocarcinoma grouping. It can occur in the breast as well as in the ovary. Tumors are normally multilocular with various smooth, thin walled cysts. Within the cysts is found a haemorrhagic or cellular debris. Honma N, Sakamoto G, Ikenaga M, Kuroiwa K, Younes M, Takubo K (August 2003). Mucinous cystadenocarcinoma of the breast: a case report and review of the literature. Arch. Pathol. Lab. Med. 127 (8): 1031-3. doi:10.1043/1543-2165(2003) ...
https://en.wikipedia.org/wiki/Mucinous_cystadenocarcinoma
The long-term survival in primary retroperitoneal mucinous cystadenocarcinoma: a case report | Surgical Case Reports | Full TextThe long-term survival in primary retroperitoneal mucinous cystadenocarcinoma: a case report | Surgical Case Reports | Full Text
The etiology and biological behavior of PRMCs are still unclear; however, some hypotheses have been proposed to explain the genesis of these tumors as follows: (1) heterotopic ovarian tissue [3, 11, 47], (2) monodermal variant of teratomas [22, 48], (3) intestinal duplication [49], and (4) coelomic metaplasia [4, 8, 12, 50]. In our case, ovarian-like stroma was histopathologically found in the tumor, although no definitive evidence of ovarian tissue was observed, which was also supported by the results of an immunohistochemical examination of the estrogen and progesterone receptors. These findings exclude the hypothesis of heterotopic ovarian tissue. In addition, the hypotheses of teratoma and intestinal duplication can also be excluded because of the lack of structures of teratoma or well-developed intestinal mucosa and smooth muscle. The fourth hypothesis, which is most well-described in the previous literature, is that PMRCs occur from invaginations of the peritoneal epithelium during ...
https://surgicalcasereports.springeropen.com/articles/10.1186/s40792-017-0394-z
An extremely rare cause of acute abdomen in pregnancy: ruptured pancreatic mucinous cystadenocarcinoma.An extremely rare cause of acute abdomen in pregnancy: ruptured pancreatic mucinous cystadenocarcinoma.
Pancreatic cystadenocarcinoma is an extremely rare neoplasm in pregnancy. To our knowledge, there have been 2 published cases of pancreatic mucinous cystadenocarcinoma (PMC) during pregnancy in the literature; one of which was reported to have ruptur
http://www.biomedsearch.com/nih/extremely-rare-cause-acute-abdomen/17446849.html
Pancreatic mucinous cystic neoplasm - WikipediaPancreatic mucinous cystic neoplasm - Wikipedia
Pancreatic mucinous cystic neoplasm, also mucinous cystic neoplasm of the pancreas and mucinous cystic tumour, is a grouping of cystic neoplasms that arise from the pancreas. They may be benign, malignant or in between. The prognosis of this set of tumours is highly variable and dependent on the specific sub-classification (benign, borderline, malignant). Mucinous cystic neoplasms of the pancreas are defined by the World Health Organization (WHO) as cystic epithelial neoplasms that occur almost exclusively in women; do not communicate with the pancreatic ductal system and which are composed of columnar, mucin-producing epithelium, supported by ovarian-type stroma. This means that these tumors make mucin (a thick sticky fluid), they do not arise in the larger pancreatic ducts, and they have a peculiar supporting stroma (or support structure). Mucinous cystic neoplasms of the pancreas classified as benign, borderline, or malignant, based on histomorphological features which predict their ...
https://en.wikipedia.org/wiki/Pancreatic_mucinous_cystic_neoplasm
Cystic pancreatic tumors] | Read by QxMDCystic pancreatic tumors] | Read by QxMD
Before 1978, where cystic tumors of the pancreas were concerned, pathologists only differentiated between cystic adenomas and cystadenocarcinomas. Recently, however, further tumor entities have been introduced. We now differentiate between the generally benign serous cystic adenoma, the potentially malignant mucinous cystadenoma, the possibly malignant papillary cystic tumor, and the always malignant mucinous cystadenocarcinoma. Other rare tumors include the solid cystic acinous-cell tumor, the cystic islet tumor, and mucinous ductal hyperplasia. Because of their slow growth and primary displacement nature, all of these tumors can usually be detected only after they have attained considerable size. Computed tomography (CT), sonography and endoscopic retrograde cholangiopancreatography (ERCP) have an established role in diagnosis. With these methods, as a rule, it is possible to identify pseudocysts; however, differentiation between the individual tumor types is almost impossible. In our study ...
https://read.qxmd.com/read/8412436/-cystic-pancreatic-tumors
Effectiveness of 2nd line chemotherapy in the treatment of ovarian cancer using | Gazeta ginekologia plEffectiveness of 2nd line chemotherapy in the treatment of ovarian cancer using | Gazeta ginekologia pl
Anti-hormonal maintenance treatment with or without the CDK4/6 inhibitor Ribociclib after 1st line chemotherapy in hormone...Anti-hormonal maintenance treatment with or without the CDK4/6 inhibitor Ribociclib after 1st line chemotherapy in hormone...
To evaluate the impact on PFS of an anti-hormonal maintenance therapy after 1st line chemotherapy at the discretion of the investigator (e.g. taxanes,
http://adisinsight.springer.com/trials/700291897?error=cookies_not_supported&code=1189532d-a824-4311-a285-9cd11514ede7
Post ovarian surgery pain - Ovarian Cancer - MedHelpPost ovarian surgery pain - Ovarian Cancer - MedHelp
This is my first post and I am hoping someone might be able to help. Can I first just say how helpful it has been over the last few months reading everyones comments and knowing what to expect. I ...
http://www.medhelp.org/posts/Ovarian-Cancer/Post-ovarian-surgery-pain/show/192088
appendiceal mucinous cystadenocarcinoma 2005:2010[pubdate] *count=100 - BioMedLib™ search engineappendiceal mucinous cystadenocarcinoma 2005:2010[pubdate] *count=100 - BioMedLib™ search engine
Anderson Cancer Center between January 1992 and December 2004 and who did not meet any of the following exclusion criteria: stage III or IV ovarian cancer, appendectomy as part of a second-look procedure or secondary tumor-reductive surgery, primary appendiceal cancer, primary gastrointestinal malignancy with metastasis to the appendix, incomplete clinicopathologic data, appendicitis as a preoperative diagnosis, primary fallopian tube cancer, primary peritoneal cancer, or documented dual primary tumors ...
http://www.bmlsearch.com/?kwr=appendiceal+mucinous+cystadenocarcinoma+2005:2010%5Bpubdate%5D&cxts=100&stmp=b0
Cystadenocarcinoma Symptoms, Causes, Ultrasound, Treatment - Health Care Tips and Natural RemediesCystadenocarcinoma Symptoms, Causes, Ultrasound, Treatment - Health Care Tips and Natural Remedies
Laparoscopy is done for cystadenocarcinoma findings. CT scan must be done for benign serous tumors and first portion is done for diagnosing the stage after evaluation of cystadenocarcinoma. MRI is the best choice of detection of ovarian cancer and detection of lymphatic and peritoneal tumor. Ultrasonography (US) provides the diagnostic feature of cystic masses in the body, it can detect 90% of cyst masses. Endoscopic ultrasound may also conduct for exact diagnosis. Ultrasound allows to capture pictures of scan for detailed evaluation. Biopsy will also provide better examination of cyst masses and provide definite diagnosis of exact forms of cystadenocarcinoma ...
http://www.healthcaretip.com/2017/08/Cystadenocarcinoma-Symptoms-Causes-Ultrasound-Treatment.html
CA54/61 as a Marker for Epithelial Ovarian Cancer<...CA54/61 as a Marker for Epithelial Ovarian Cancer<...
TY - JOUR. T1 - CA54/61 as a Marker for Epithelial Ovarian Cancer. AU - Nozawa, Shiro. AU - Aoki, Daisuke. AU - Yajima, Masazumi. AU - Tsukazaki, Katsumi. AU - Kobayashi, Toshibumi. N1 - Copyright: Copyright 2016 Elsevier B.V., All rights reserved.. PY - 1992/3. Y1 - 1992/3. N2 - Using a new one-step, double-determinant enzyme immunoassay, we performed quantitative measurements of a mucin-type glycoprotein antigen (CA54/61) that we recently detected in sera of ovarian carcinoma patients. When the cutoff value was set at 12 units/ml, at which a high diagnostic efficiency was demonstrated [or at 20 units/ml (mean + 3 SD of healthy females)], the positive rates of ovarian serous, mucinous, clear cell, and endometrioid carcinomas were 76% (or 63%), 63% (or 55%), 57% (or 52%), and 50% (or 38%), respectively. Even in mucinous cystadenocarcinoma, more than one-half of the cases were positive, indicating the potential utility of the assay in the diagnosis of mucinous tumors. In sera from patients with ...
https://keio.pure.elsevier.com/en/publications/ca5461-as-a-marker-for-epithelial-ovarian-cancer
EDUCATION AND IMAGING. Hepatobiliary and Pancreatic: Long-term survival of serous cystadenocarcinoma of the pancreas with...EDUCATION AND IMAGING. Hepatobiliary and Pancreatic: Long-term survival of serous cystadenocarcinoma of the pancreas with...
Semantic Scholar extracted view of EDUCATION AND IMAGING. Hepatobiliary and Pancreatic: Long-term survival of serous cystadenocarcinoma of the pancreas with synchronous liver metastases after aggressive surgical resection. by Hayato Sasaki et al.
https://www.semanticscholar.org/paper/EDUCATION-AND-IMAGING-Hepatobiliary-and-Pancreatic-Sasaki-Murakami/306004793c63c30c6bdff4c3920073b9c9ed5fa4
LPAR1 regulates the development of intratumoral heterogeneity in ovarian serous cystadenocarcinoma by activating the PI3K/AKT...LPAR1 regulates the development of intratumoral heterogeneity in ovarian serous cystadenocarcinoma by activating the PI3K/AKT...
To explore the role of lysophosphatidic acid receptor 1 (LPAR1) and its correlation with the PI3K/AKT pathway in the development of intratumoral heterogeneity (ITH) in human ovarian serous cystadenocarcinoma (OSC). Immunohistochemical staining was performed to detect LPAR1 expression in matched primary and recurrent lesions from the same patients. Cell models of ITH were established using the limiting dilution methodology and Transwell invasion/migration assays. LPAR1 expression in the ITH cell models was silenced or upregulated with lentiviral particles, and the biological characteristics were evaluated using various in vitro and in vivo assessments of cell function. The levels of phosphorylated PI3K/AKT (p-PI3K/p-AKT) in LPAR1 knockdown and LPAR1-overexpressing cells were detected. The H-scores for LPAR1 staining in the lymphatic metastatic and recurrent lesions were noticeably higher than in the primary tumor lesions from the same patients (P = 0.024/0.031). High LPAR1 expression was associated with
https://cancerci.biomedcentral.com/articles/10.1186/s12935-019-0920-0
Microcystic (Serous) Neoplasm - Radiology ImagingMicrocystic (Serous) Neoplasm - Radiology Imaging
Some authors believe the term microcystic serous adenoma is too limiting and that a macrocystic variant of the same neoplasm exists; the term serous cystadenoma is thus used for both morphologic variants.Nevertheless, the term macrocystic serous tumor is useful; these tumors are often misdiagnosed as either mucinous cystic neoplasms or pseudocysts. In fact, some tumors are misclassified even with intraoperative frozen section. Serum tumor markers with macrocystic serous tumors tend to be normal, although CA 125 and CA 19-9 are elevated in the cyst fluid in some of these tumors. The macrocystic variant of serous adenoma consists of a small uni- or bilocular cyst containing a thin wall without any mural nodules; these are indistinguishable from mucinous cystic tumors ...
http://radiology-information.blogspot.com/2014/04/microcystic-serous-neoplasm.html
A case of mucinous cystic neoplasm of the liver: a case report | Surgical Case Reports | Full TextA case of mucinous cystic neoplasm of the liver: a case report | Surgical Case Reports | Full Text
A 71-year-old woman was referred to our institution for further investigation of epigastric pain. The patient had been detected to have a multilocular cyst in the medial segment of the liver measuring 69 mm in diameter at another hospital 2 years ago, and the diameter of the cyst had increased to 90 mm. Although the cyst had gradually increased in size, there was no evidence of mural nodules. As we were concerned about the malignant potential of the lesion, a left hepatic segmentectomy was performed. Pathologically, the cyst was lined by columnar and cuboidal epithelium with low-grade atypia. The epithelium covered an ovarian-like stroma, and the diagnosis was mucinous cystic neoplasm of the liver (MCN-L) with low-grade intraepithelial neoplasia. MCN-L is a rare disease and its characteristics are still poorly understood. MCN-L occurs at a lower frequency as compared to the counterpart of MCN of the pancreas, further investigations are necessary to clarify the biological malignancy of MCN-L.
https://surgicalcasereports.springeropen.com/articles/10.1186/s40792-014-0007-z/tables/2
Large Ovarian Cyst With Fever | Ovarian Cyst Natural Treatment Options - What You Should Know!Large Ovarian Cyst With Fever | Ovarian Cyst Natural Treatment Options - What You Should Know!
We report a case of a mural nodule of anaplastic spindle cell carcinoma in an ovarian mucinous cystic tumor of borderline malignancy. The thing is you may have more than one cysts and though 1 had ruptured, it can cause others to be inflamed or prone to break - like a chain reaction.. It seems that in patients whom follow a treatment against infertility with womanly hormones like FSH the risk of functional cysts to form is very high. Macrophages killed the cysts by phagocytosis, whereas neutrophils wiped out cysts through the secretion of MPO.. Individuals were followed up 24 instances of being pregnant 15 instances of infertility, pregnancy level 62. 5%; 5 instances confirmed recurrence, the recurrence rate was 5. 3%. Conclusions Laparoscopic surgical injury, quicker recovery, pelvic obvious vision, releasable pelvic adhesions in individuals with increased being pregnant rate of infertility, ovarian endometriosis must be used since the preferred way of cyst. ...
http://ovarian-cyst-relief.com/ovarian-cyst-pain/large-ovarian-cyst-with-fever/
Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International...Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International...
Results 2622 patients were included. Seventy-four per cent were women, and median age at diagnosis was 58 years (16-99). Patients presented with non-specific abdominal pain (27%), pancreaticobiliary symptoms (9%), diabetes mellitus (5%), other symptoms (4%) and/or were asymptomatic (61%). Fifty-two per cent of patients were operated on during the first year after diagnosis (median size: 40 mm (2-200)), 9% had resection beyond 1 year of follow-up (3 years (1-20), size at diagnosis: 25 mm (4-140)) and 39% had no surgery (3.6 years (1-23), 25.5 mm (1-200)). Surgical indications were (not exclusive) uncertain diagnosis (60%), symptoms (23%), size increase (12%), large size (6%) and adjacent organ compression (5%). In patients followed beyond 1 year (n=1271), size increased in 37% (growth rate: 4 mm/year), was stable in 57% and decreased in 6%. Three serous cystadenocarcinomas were recorded. Postoperative mortality was 0.6% (n=10), and SCNs related mortality was 0.1% (n=1). ...
http://gut.bmj.com/content/65/2/305
endometrial carcinoma mucinous drug therapy 2000:2010[pubdate] *count=100 - BioMedLib™ search engineendometrial carcinoma mucinous drug therapy 2000:2010[pubdate] *count=100 - BioMedLib™ search engine
MeSH-minor] Adenocarcinoma, Mucinous / drug therapy. Adenocarcinoma, Mucinous / metabolism. Adenocarcinoma, Mucinous / pathology. Benzamides. Carboplatin / administration & dosage. Carcinoma, Papillary / drug therapy. Carcinoma, Papillary / metabolism. Carcinoma, Papillary / pathology. Cystadenocarcinoma, Serous / drug therapy. Cystadenocarcinoma, Serous / metabolism. Cystadenocarcinoma, Serous / pathology. Endometrial Neoplasms / drug therapy. Endometrial Neoplasms / metabolism. Endometrial Neoplasms / pathology. Female. Humans. Imatinib Mesylate. Immunoenzyme Techniques. Paclitaxel / administration & dosage. Piperazines / administration & dosage. Proto-Oncogene Proteins c-abl / genetics. Proto-Oncogene Proteins c-abl / metabolism. Proto-Oncogene Proteins c-kit / genetics. Proto-Oncogene Proteins c-kit / metabolism. Pyrimidines / administration & dosage. RNA, Messenger / genetics. RNA, Messenger / metabolism. RNA, Neoplasm / genetics. RNA, Neoplasm / metabolism. Tissue Array Analysis. Tumor ...
http://www.bmlsearch.com/?kwr=endometrial+carcinoma+mucinous+drug+therapy+2000:2010%5Bpubdate%5D&cxts=100&stmp=b1
Reproductive factors and risk of ovarian cancer: a prospective study. - Clinical Trial Service Unit & Epidemiological Studies...Reproductive factors and risk of ovarian cancer: a prospective study. - Clinical Trial Service Unit & Epidemiological Studies...
Associations between reproductive factors and risk of ovarian cancer were examined in a prospective study of 60,565 women in Norway. A total of 445 women were diagnosed as having ovarian cancer during follow-up, from 1961 through 1980. The highest risk was observed among nulliparous women, and the risk decreased significantly with increasing parity. The estimated odds ratio for women with 5 or more births compared with one birth was 0.46, after adjustment for age, urban/rural place of residence and occupational class. Neither age at first or last birth, nor age at menarche or menopause, nor marital status, showed significant associations with ovarian cancer risk after adjustment for parity. The apparent protective effect of high parity was observed for epithelial as well as non-epithelial cancers, and for the separate histological types of epithelial cancer except mucinous cystadenocarcinomas.
https://www.ctsu.ox.ac.uk/publications/35333/
SurgPath4U Case ViewerSurgPath4U Case Viewer
Mucinous cystadenocarcinomas are currently broadly divided into two types based on their pattern of invasion. The expansile type consists of back to back glands, with very little intervening stroma. Interobserver variability definitely exists for this diagnosis, for while some pathologists may call a mucinous carcinoma expansile-type invasion, others may assert the same entity to be an intraglandular carcinoma or even non-invasive. However, these differences are not as egregious as one would think, for intraglandular, borderline and expansile (also known as confluent) type carcinomas are usually indolent, stage I tumors that do not spread beyond the ovary (Lee). ...
https://surgpath4u.com/caseviewer.php?case_no=538
Chapter 58. Cystic Neoplasms of the Pancreas | Maingots Abdominal Operations, 12e | AccessSurgery | McGraw-Hill MedicalChapter 58. Cystic Neoplasms of the Pancreas | Maingots Abdominal Operations, 12e | AccessSurgery | McGraw-Hill Medical
An ideal diagnostic approach would allow for the resection of only those lesions with present or near-future risk of malignancy, while excluding from surgery those individuals with either benign lesions or a prohibitive operative risk, thus minimizing the potential occurrence of mortality and morbidity associated with the surgical treatment of these cystic lesions. Recent advancements in imaging by CT, MRI, and endoscopic ultrasonography (EUS), linked with refinements in the pathological understanding of cystic neoplasms of the pancreas have furthered this effort. History and clinical criteria, such as age, gender, presence of symptoms, location of the neoplasm within the pancreas, as well as, morphology by cross-sectional imaging and cyst fluid analysis by EUS with fine-needle aspiration (EUS-FNA), all may play a role in the diagnosis of pancreatic cystic neoplasms and assessment of the need for resection. A recent analysis using decision analysis with Markov modeling has indicated that for ...
https://accesssurgery.mhmedical.com/content.aspx?bookid=531§ionid=41808848
salivary low-grade cribriform adenocarcinoma - Humpath.com - Human pathologysalivary low-grade cribriform adenocarcinoma - Humpath.com - Human pathology
Low-grade cribriform cystadenocarcinoma of salivary glands Definition : Low-grade cribriform cystadenocarcinoma (LGCCC) is a recently described (...)
https://www.humpath.com/spip.php?article22973
Oral cavity - CystadenocarcinomaOral cavity - Cystadenocarcinoma
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patients clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician ...
http://www.pathologyoutlines.com/topic/oralcavitycystadenocarcinoma.html
Polyembryoma ovarian | surgery treatment. Gynecology: Treatment in Switzerland, Lucerne hospitals on BookingHealth.comPolyembryoma ovarian | surgery treatment. Gynecology: Treatment in Switzerland, Lucerne hospitals on BookingHealth.com
Polyembryoma ovarian | surgery treatment. Gynecology: Treatment in Lucerne, Switzerland ✈. Prices on BookingHealth.com - booking treatment online!
https://bookinghealth.com/programs/treatment/gynecology/polyembryoma-surgery-treatment/switzerland/lucerne
Gynecology: Polyembryoma ovarian | surgery treatment. Treatment in Marburg, Germany | BookingHealthGynecology: Polyembryoma ovarian | surgery treatment. Treatment in Marburg, Germany | BookingHealth
Gynecology: Polyembryoma ovarian | surgery treatment. Treatment in Marburg, Germany ✈ Find the best medical programs at BookingHealth - ✔Compare the prices ✔Online booking.
https://bookinghealth.com/programs/treatment/gynecology/polyembryoma-surgery-treatment/germany/marburg
Clinical Trials Registry | Internet Stroke CenterClinical Trials Registry | Internet Stroke Center
have been recently diagnosed at hospital or in private-sector for the following diseases: Local or metastatic cancer diagnosed less than 6 month (breast cancer-hormone sensitive- in first line chemotherapy treatment, hormone-sensitive prostate cancer or in metastatic recurrence after 3 years of remission, considered as a new case, colorectal cancer in first line chemotherapy treatment), a neuro-degenerative disease (Parkinson disease diagnosed less than 7 years, Alzheimer disease and similar diseases diagnosed less than 12 months and /or with a Mini Mental State Examination (MMSE ...
http://www.strokecenter.org/trials/clinicalstudies/multicenter-prospective-cohort-of-informal-caregivers-in-burgundy-and-franche-comt%C3%A9/eligibility
Plus itPlus it
Despite being implicated in multiple types of human epithelia-origin cancer, laminin-binding (LB) integrins (e.g., α3α1 and α6β4) have rarely been investigated for their roles in human ovarian tumors. More recently, we and others have shown that CD151, a member of the tetraspanin family, not only forms tight surface complexes with these adhesion receptors, but also mediates the malignancy of human carcinomas largely in a LB integrin-dependent manner. Here we report our studies on the role of CD151 in human ovarian cancer. Initially, we stained human ovarian tumor tissue microarrays with CD151-specific antibody. Our data showed that the majority of ovarian tumors exhibited a reduced expression of CD151 protein, compared to the fallopian tube, implying a putative suppressing role of this tetraspanin in ovarian cancer. With this hint we next evaluated the impact of CD151 ablation on the behaviors and proliferation of cultured human ovarian cancer cells. While CD151 removal had a minimal impact ...
http://cancerres.aacrjournals.org/content/72/8_Supplement/4613
Secondary (metastatic) ovarian tumors | MEDICHSecondary (metastatic) ovarian tumors | MEDICH
Metastatic neoplasms are secondary ovarian tumors. The main sources of metastasis are carcinomas of the stomach, intestines, breast and uterus.
http://medich.net/secondary-metastatic-ovarian-tumors/
Magnetic Resonance Angiography of Anomalous Coronary Arteries | CirculationMagnetic Resonance Angiography of Anomalous Coronary Arteries | Circulation
From one of the patients included, the original x-ray coronary angiogram could not be traced by the referring cardiologist. Furthermore, the two independent observers reviewing all x-ray coronary angiograms both judged that the coronary angiogram of 1 patient could not be analyzed because it was an incomplete study. Of the remaining 36 films, observer A judged 19 angiograms to show normal coronary anatomy and 17 to show anomalously arising coronary arteries, whereas observer B judged 20 to show normal and 16 to show anomalous anatomy. Interobserver agreement for differentiating anomalous from normal coronary anatomy was 97%. In 5 of the patients, there was difference in opinion about the site of origin of an (anomalous) artery. In 4 of these 5 patients, the disagreement consisted of one of the observers having labeled the origin of an anomalous artery as unclear, whereas the other had specified an anomalous origin (in 3 patients, an anomalous origin of the RCA from or from above the left sinus ...
http://circ.ahajournals.org/content/92/11/3163
Primary pancreatic cystic neoplasms revisited. Part I: Serous cystic neoplasms<...Primary pancreatic cystic neoplasms revisited. Part I: Serous cystic neoplasms<...
TY - JOUR. T1 - Primary pancreatic cystic neoplasms revisited. Part I. T2 - Serous cystic neoplasms. AU - Sakorafas, George H.. AU - Smyrniotis, Vasileios. AU - Reid-Lombardo, Kaye M.. AU - Sarr, Michael G.. PY - 2011/6/1. Y1 - 2011/6/1. N2 - Primary pancreatic cystic neoplasms have been recognized increasingly during the two recent decades and include mainly serous cystic neoplasms, mucinous cystic neoplasms, and intraductal papillary mucinous neoplasms. Serous cystic neoplasms represent about 30% of all cystic neoplasms of the pancreas and are characterized by their microcystic appearance (on imaging, macroscopically, and microscopically) and their benign biologic behavior. Modern diagnostic methodology allows the preoperative diagnosis with an acceptable accuracy. Currently, indications for resection of serous cystic neoplasms of the pancreas include the presence of symptoms, size , 4 cm (because these large neoplasms have a more rapid growth rate and probably will soon become symptomatic), ...
https://mayoclinic.pure.elsevier.com/en/publications/primary-pancreatic-cystic-neoplasms-revisited-part-i-serous-cysti
Vesalius Clinical Folios: Mucinous Cystadenoma of the AppendixVesalius Clinical Folios: Mucinous Cystadenoma of the Appendix
A close-up of the smooth appendiceal luminal surface is shown. Differential diagnosis included mucocele, mucinous cystadenoma, mucinous cystadenocarcinoma and less likely, carcinoid ...
http://vesalius.com/cfoli_frms.asp?VID=1029&StartFrame=58&tnVID=1030
Ovarian Cyst And Constant Bleeding - Ovarian Cyst Removal | Ovarian Cyst Natural Treatment Options - What You Should Know!Ovarian Cyst And Constant Bleeding - Ovarian Cyst Removal | Ovarian Cyst Natural Treatment Options - What You Should Know!
The only method you can actually tell how big an ovarian cyst is by going into your physician for an ultrasound. However, kids arent spared of Dermoid cysts - often children get them near to the eyebrows spectrum of ankle aspect and so they feel like rubberized. Many different steps are there in treating Ovarian cyst patients in respect to their person condition. Mucinous cystadenocarcinoma is usually unilateral and involve the existence of irregular dense septa or solid papillary projections which can be usually recognized within cysts ( Fig.. There are generally only a couple of options for treatment; one is surgical removal of the cysts, and the additional is body hormone treatment by means of birth control supplements. She was told the fact that ultrasound search within will be repeated in a few a few months time; in the event the cysts develop larger, they need to be eliminated by medical procedures.. However , a functional cyst may interrupt your menstrual cycle simply by preventing ...
http://ovarian-cyst-relief.com/ovarian-cyst-removal/ovarian-cyst-and-constant-bleeding-ovarian-cyst-removal/
Familial association of specific histologic types of ovarian malignancy with other malignancies - Bermejo - 2004 - Cancer -...Familial association of specific histologic types of ovarian malignancy with other malignancies - Bermejo - 2004 - Cancer -...
Ovarian malignancy was found to be associated with ovarian, laryngeal, breast, endometrial, liver, and colon carcinoma, as well as myeloma; epithelial ovarian malignancy was found to be associated with ovarian, endometrial, and skin malignancies and with melanoma and myeloma; papillary serous cystadenocarcinoma was found to be associated with ovarian and skin malignancies and with myeloma; and endometrioid carcinoma was found to be associated with endometrial, ovarian, and prostate malignancies and with melanoma. For younger women (ages 40-45 years) whose mothers were affected with endometrial malignancies, the risk of developing endometrioid carcinoma was slightly greater than the risk of developing papillary serous cystadenocarcinoma. ...
http://onlinelibrary.wiley.com/doi/10.1002/cncr.20138/abstract
Cystic Neoplasms - Herb Kosten FoundationCystic Neoplasms - Herb Kosten Foundation
Cystic neoplasms of the pancreas represent about 10% of all cysts of the pancreas and ~1% of all pancreatic neoplasms. Much has been learned about the natural history and management of these tumors in the past decade. We are finding more of these lesions than in years past since so many patients receive ultrasounds or CT scans for other reasons and these tumors are found incidentally. Cystic neoplasms are subdivided into serous, mucinous and intraductal papillary mucinous neoplasms. These lesions are described separately on this website but a few generalities pertain to all. The most important aspect of these lesions is to recognize them. They must be differentiated from benign pancreatic cysts as the treatment is distinctly different. Differentiation of benign cysts from cystic neoplasms of the pancreas can usually be made by a good history and physical exam by a physician familiar with these disorders. If a cystic neoplasm is suspected and the patient is symptomatic (abdominal pain), surgical ...
https://www.kostenfoundation.com/cystic-neoplasms/
Week 365: Case 4 | Johns Hopkins Surgical Pathology Unknown ConferenceWeek 365: Case 4 | Johns Hopkins Surgical Pathology Unknown Conference
Answer: Mucinous cystic neoplasm. Histology: This unusual neoplasm is has two distinct components. The stroma has the appearance of ovarian stroma, and indeed the stromal cells immunolabeled for estrogen and progesterone receptors. The second component is composed of epithelial cells. These cells are mostly cuboidal and occasionally have a hobnail appearance.. Discussion: Mucinous cystic neoplasms of the pancreas occur in women more frequently than they do in men, and mucinous cystic neoplasms have a distinctive ovarian-type of stroma. The neoplasm presented arose in a woman and it has ovarian stroma. One might expect that it is a classical mucinous cystic neoplasm, but two things are peculiar about this case. First, the epithelial cells do not form large cysts. Second, the epithelial cells are not columnar mucin-producing cells. Instead, they are mostly cuboidal and somewhat hob-nailed in appearance. This histologic appearance is almost identical to the mixed epithelial and stromal tumor ...
http://apps.pathology.jhu.edu/sp/week-1-case-1-2172/
Cystadenocarcinoma | CTDCystadenocarcinoma | CTD
A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed ...
http://ctdbase.org/detail.go?type=disease&acc=MESH%3AD003536
A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.
This 4 arm study will assess the optimal starting dose of Mircera in the treatment of anemia in patients with non-small cell lung cancer receiving first
http://www.knowcancer.com/cancer-trials/NCT00327535/
pancreatic simple mucinous cyst - Humpath.com - Human pathologypancreatic simple mucinous cyst - Humpath.com - Human pathology
See also pancreatic anomalies simple mucinous cyst Open references A Revised Classification System and Recommendations From the Baltimore (...)
http://humpath.com/spip.php?article21902
Data Availability StatementThe datasets used and/or analyzed during the current research are available through the...Data Availability StatementThe datasets used and/or analyzed during the current research are available through the...
Data Availability StatementThe datasets used and/or analyzed during the current research are available through the corresponding writer on reasonable demand. expression groupings. Furthermore, sufferers with low CDCA7 appearance exhibited a larger overall survival price of CRC in comparison to people that have high CDCA7 appearance. The results of the research indicated that CDCA7 may provide a substantial function in CRC prognosis and development, and may be considered a novel biomarker for the prediction of individual survival after colectomy. (14) exhibited that CDCA7 protein is usually upregulated in Burkitt lymphoma cell lines and tumor tissues, and CDCA7 mRNA levels are significantly elevated in numerous T and B lymphoma cell lines. In addition, a previous study reported that CDCA7 is usually overexpressed in the YDOV-151 human ovarian malignancy cell collection ( 7-fold expression) weighed against in individual ovarian surface area epithelial cells (10). Furthermore, CDCA7 continues to be ...
http://aqualogy.org/%EF%BB%BFdata-availability-statementthe-datasets-used-and-or-analyzed-during-the-current-research-are-available-through-the-corresponding-writer-on-reasonable-demand/
DeCS Ingl s+escopoDeCS Ingl s+escopo
Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. . ...
http://trigramas.bireme.br/cgi-bin/mx/[email protected]?collection=DeCSxi&lang=i&minsim=0.30&maxrel=10&text=Intracranial%20Neoplasm
Deakin University / All LocationsDeakin University / All Locations
Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain ...
http://library.deakin.edu.au/search~S1?/dBrain./dbrain/-3,-1,0,B/browse
Mucinous cystadenoma and cystadenocarcinoma - Herb Kosten FoundationMucinous cystadenoma and cystadenocarcinoma - Herb Kosten Foundation
Mucinous cystadenoma is a type of cystic neoplasm. This type of tumor is usually benign when small but can grow and degenerate into a frank cancer. Most patients with these tumors are in their 5th and 6th decade and it is more common in women. Most of these tumors occur in the body and tail of the pancreas. As with serous cystadenomas they can usually be definitely diagnosed with modern diagnostic testing. When small (,3cm) and asymptomatic, most experts feel these lesions can be safely observed provided there is close surveillance with CT scans. If the lesion is ,3cm, causing symptoms or obstructing the pancreatic duct they should be surgically excised. Even if a cystadenocarcinoma is found, the prognosis is quite good if the tumor can be surgically removed.. ...
https://www.kostenfoundation.com/mucinous-cystadenoma-and-cystadenocarcinoma/
Intrahepatic cystadenocarcinoma with pleural dissemination: a case report. - Semantic ScholarIntrahepatic cystadenocarcinoma with pleural dissemination: a case report. - Semantic Scholar
A 40-year-old Japanese woman, who previously had undergone choledocho-jejunostomy in childhood for a congenital choledocal cyst, presented with right-sided chest pain. Computed tomography and ultrasonography demonstrated a right pleural effusion and a 10-cm unilocular hepatic cystic lesion with no solid component. These findings suggested a non-neoplastic cyst or cystadenoma. However, intracystic fluid aspirated had high concentrations of carbohydrate antigen 19-9 and carcinoembryonic antigen. Cytology of the pleural effusion demonstrated malignant cells. During exploratory laparo- and thoracotomy, a hepatic cystadenocarcinoma with invasion of the diaphragm and pleural dissemination was discovered. This case demonstrates that malignancy should be ruled out when a patient with an intrahepatic unilocular cystic lesion presents with atypical symptoms and findings, such as chest pain, pleural effusion, and high serum concentration of tumor markers. We believe that intrahepatic cystic lesions should be
https://www.semanticscholar.org/paper/Intrahepatic-cystadenocarcinoma-with-pleural-disse-Hai-Hirohashi/dc607fb4b102e7a4e2e7d6e300950de480cfdb26
A prospective study on endoscopic ultrasound for the differential diagnosis of serous cystic neoplasms and mucinous cystic...A prospective study on endoscopic ultrasound for the differential diagnosis of serous cystic neoplasms and mucinous cystic...
To provide criteria for the differential diagnosis of serous cystic neoplasms (SCNs) and mucinous cystic neoplasms (MCNs) by analyzing the imaging features of these two neoplasms by endoscopic ultrasound (EUS). From April 2015 to December 2017, a total of 69 patients were enrolled in this study. All patients were confirmed to have MCNs (31 patients) or SCNs (38 patients) by surgical pathology. All patients underwent EUS examination. The observation and recorded items were size, location, shape, cystic wall thickness, number of septa, and solid components. Head/neck location, lobulated shape, thin wall and | 2 septa were the specific imaging features for the diagnosis of SCNs. When any two imaging features were combined, we achieved the highest area under the curve (Az) (0.824), as well as the appropriate sensitivity (84.2%), specificity (80.6%), positive predictive value (PPV) (84.2%), and negative predictive value (NPV) (80.6%). Body/tail location, round shape, thick wall and 0-2 septa were the
https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-019-1035-8/tables/1
Use of immunohistochemical staining panel for characterisation of ovarian neoplasms. | Journal of Clinical PathologyUse of immunohistochemical staining panel for characterisation of ovarian neoplasms. | Journal of Clinical Pathology
Eighty five ovarian epithelial and non-epithelial tumours were studied by peroxidase histochemical staining for their reactivity with six monoclonal human milk fat globule (HMFG) antibodies, peanut agglutinin (PNA) lectin, and a monoclonal cytokeratin antibody. HMFG IIIC12 and cytokeratin antibodies distinguished epithelial from non-epithelial tumours. The staining patterns of mucinous and serous tumours were essentially different from each other; poorly differentiated anaplastic carcinomas showed similar antigenic content to that of the serous cystadenocarcinomas. Furthermore, staining with PNA lectin and HMFG antibodies was useful in distinguishing clear cell carcinomas from other malignant epithelial tumours of the ovary.. ...
http://jcp.bmj.com/content/41/1/12
Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm - Full Text View -...Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm - Full Text View -...
Endoscopic ultrasound will be used to locate and assess the pancreatic cyst. The fluid contents will be aspirated using a fine needle and sent for tumor marker analysis and cytology. With the needle maintained in the same position, 99% ethanol will be injected into the cyst. After 3-5 minutes of lavage, the entire volume of fluid will be removed from the cyst. The same volume of paclitaxel minus 1 mL [3mg/ml diluted in normal saline from original concentration of 6mg/mL] will be injected and left in the cyst. The needle is then retracted and the procedure completed. Patients will receive oral prophylactic antibiotics for 5 days after the procedure. Clinical follow up with MRI imaging with be done at 6, 12, 18, and 24 months. For those with a persistent cyst at 12 months, a repeat EUS FNI procedure will be done ...
https://clinicaltrials.gov/ct2/show/NCT01525706?cond=%22Adenocarcinoma+of+the+appendix%22&rank=13
Cancer Detection in Pancreatic Cysts - Full Text View - ClinicalTrials.govCancer Detection in Pancreatic Cysts - Full Text View - ClinicalTrials.gov
The study of pancreatic diseases is hindered by the organs deep seated location and especially lack of symptoms during the early stages of disease development and progression e.g. pancreatic cancer. This is particularly true of pancreatic cysts, the variety and the malignant potential of which encompass a broad spectrum. The radiological features distinguishing a benign from a pre-malignant to a frankly malignant cyst in the pancreas are frequently underwhelming and have lead to the clinical practice of sampling all but the most obvious. The yield of the aspirate in turn is frequently not of a quality upon which a clinical decision can be based.. Most would agree that the best approach for management of pancreatic cystic neoplasm lies in early diagnosis, ideally at a precancerous stage. The effectiveness and applicability of this study is the based on the ability of the cyst DNA analysis to stratify the patients at risk of developing pancreatic cancer based on the extent of accumulated ...
https://www.clinicaltrials.gov/ct2/show/NCT00222898
JCDR - Evaluation of Clinical Parameters to Distinguish Mucinous Cystic Neoplasms from Serous Cystic Neoplasms of...JCDR - Evaluation of Clinical Parameters to Distinguish Mucinous Cystic Neoplasms from Serous Cystic Neoplasms of...
Journal of Clinical and Diagnostic Research aims to publish findings of doctors at grass root level and post graduate students, so that all unique medical experiences are recorded in literature.
http://www.jcdr.net/article_abstract.asp?issn=0973-709x&year=2017&volume=11&issue=10&page=XC06&issn=0973-709x&id=10748
Cisplatin plus oral vinorelbine as first line chemotherapy in patients with triple negative advanced breast cancer - AdisInsightCisplatin plus oral vinorelbine as first line chemotherapy in patients with triple negative advanced breast cancer - AdisInsight
This trial will evaluate the efficacy and safety of oral vinorelbine-cisplatin (OV-P) in first line advanced triple negative breast cancer (ATNBC).
http://adisinsight.springer.com/trials/700266919?error=cookies_not_supported&code=0be40de9-586c-4e93-8020-188fe7cbab1c
Plus itPlus it
Purpose: Pancreatic cysts are common and pose diagnostic and management challenges. Pancreatic cyst fluid markers have the potential to aid in the management of cysts with concerning imaging findings. Our aim was to evaluate cyst fluid methylated DNA markers for their accuracy for predicting the histologic grade of neoplastic pancreatic cysts. Experimental Design: Pancreatic cyst fluid samples from 183 patients (29 discovery, 154 validation) aspirated after surgical resection were analyzed for methylated DNA at selected genes (SOX17, BNIP3, FOXE1, PTCHD2, SLIT2, EYA4 and SFRP1) using methylation-specific droplet-digital PCR (dd-QMSP). Methylated DNA levels were evaluated for their accuracy at predicting the grade of dysplasia of the pancreatic cyst. Results: All six markers evaluated in the validation set could accurately distinguish high-risk cystic neoplasms (with high-grade dysplasia and/or associated invasive cancer) from low-risk cysts (lower grades of dysplasia) with accuracies from 79.8 ...
http://clincancerres.aacrjournals.org/content/early/2017/02/01/1078-0432.CCR-16-2244
An Unusual Association of Lung and Ovarian Malignancy in a Young Nonsmoker Female: Medicine & Healthcare Journal Article | IGI...An Unusual Association of Lung and Ovarian Malignancy in a Young Nonsmoker Female: Medicine & Healthcare Journal Article | IGI...
An Unusual Association of Lung and Ovarian Malignancy in a Young Nonsmoker Female: 10.4018/ijudh.2012100104: Lung cancer in a 25-year-old nonsmoker female is extremely rare. Ovarian malignancy in this age group is also infrequent and if occurs, is usually of germ
https://www.igi-global.com/article/unusual-association-lung-ovarian-malignancy/75177
What are the clinical findings of neoplastic cysts of the liver?What are the clinical findings of neoplastic cysts of the liver?
Cystadenoma most often occurs in middle-aged women. However, cystadenocarcinoma equally affects both men and women. Most patients are asymptomatic or have vague abdominal complaints of bloating, nause... more
https://www.medscape.com/answers/190818-82236/265548-overview
Diagnosing Pancreatic Cysts | Learn about pancreatic cysts and the risk of pancreatic cancerDiagnosing Pancreatic Cysts | Learn about pancreatic cysts and the risk of pancreatic cancer
If you have a pancreatic cyst, it is important that you get a timely and accurate diagnosis to confirm whether or not your cyst contains cancer cells so that prompt treatment can occur.
https://diagnosingpancreaticcysts.org/
Pancreatic Cysts | Memorial Sloan Kettering Cancer CenterPancreatic Cysts | Memorial Sloan Kettering Cancer Center
Pancreatic cysts are small, fluid-filled growths in the pancreas that can be cancerous or noncancerous. They sometimes grow as a result of pancreatitis, but most develop for no apparent reason. Learn about your options for having pancreatic cysts treated or watched for signs of change over time.
https://www.mskcc.org/cancer-care/types/pancreatic-cysts
Johns Hopkins Medicine: Pancreatic CystsJohns Hopkins Medicine: Pancreatic Cysts
Anne Marie Lennon, MD, PhD, director of the Pancreatic Cyst Clinic discusses the prevalence and optimal management of pancreatic cysts.
http://joh.broadcastmed.net/videos/pancreatic-cysts
Accuracy of CT in predicting malignant potential of cystic pancreatic neoplasmsAccuracy of CT in predicting malignant potential of cystic pancreatic neoplasms
Specific preoperative diagnosis of pancreatic cystic neoplasms by CT alone is substantially inaccurate. Complementary tests such as EUS-FNA with fluid analysis and ERCP should be recommended to improve diagnosis especially if nonoperative treatment is planned.
https://pubmed.ncbi.nlm.nih.gov/19088937/
Cancer Treatment Resource: TAPUR | Honolulu Legal Examiner | Honolulu Hawaii Personal Injury LawyerCancer Treatment Resource: TAPUR | Honolulu Legal Examiner | Honolulu Hawaii Personal Injury Lawyer
TAPUR stands for Targeted Agent and Profiling Utilization Registry - it is a beacon of hope for cancer patients seeking treatment when first line chemotherapy...
http://honolulu.legalexaminer.com/defective-dangerous-products/cancer-treatment-resource-tapur/
Pancreatic cysts - Symptoms and causes - Mayo ClinicPancreatic cysts - Symptoms and causes - Mayo Clinic
Most pancreatic cysts are benign, but some types are cancerous. Find out about symptoms, causes and treatment of cysts in the pancreas.
https://www.mayoclinic.org/diseases-conditions/pancreatic-cysts/symptoms-causes/syc-20375993
Pancreatic Cysts</span><span class...Pancreatic Cysts</span><span class...
Cysts are responsible for secreting fluid into the cysts, that can be harmful. The Treatment For Pancreatic Cysts In Delhi available for the sufferer.
http://www.drashishbhanot.com/pancreatic-cysts/
Pancreatic Cyst Care | Hoag USC-Digestive InstitutePancreatic Cyst Care | Hoag USC-Digestive Institute
When it comes to pancreatic cysts, expert evaluation is vital to accurately diagnose the nature of the cyst, and then determine the best course of treatment.
https://www.hoag.org/specialties-services/other-programs-services/digestive-health/conditions/pancreatic-cysts-intraductal-papillary-mucinous-/treatment-options/
Ovarian Cancer Thwarts Immune Cells by Revving up Stress | Newsroom | Weill Cornell MedicineOvarian Cancer Thwarts Immune Cells by Revving up Stress | Newsroom | Weill Cornell Medicine
Ovarian tumors disable the immune systems killer T cells-which protect the body by destroying infected or malignant cells-enabling the disease to flourish unchecked, according to a new study by Weill Cornell Medicine scientists. The findings show that adverse conditions within ovarian tumors cause detrimental stress responses in T cells, a process that paralyzes them.. The study, published Oct. 10 in Nature, shows that ovarian cancer inhibits the T cells activity by disturbing the equilibrium of their endoplasmic reticulum (ER), the cellular component that is responsible for assembling proteins. This renders the T cells unable to seek and destroy tumor cells and may explain why ovarian cancers dont respond well to current immunotherapies such as checkpoint blockade, which acts to release some of the common brakes that impede T cell function in cancer. However, experiments using T cells collected from human ovarian tumors, as well as in mice with ovarian cancer, showed that turning off this ...
https://news.weill.cornell.edu/news/2018/10/ovarian-cancer-thwarts-immune-cells-by-revving-up-stress
What are ovarian malignancies?What are ovarian malignancies?
Ovarian cancer is a silent killer; however, improvements in identification of women at high risk for ovarian cancer, as well as improved imaging techniques, have increased the likelihood of early dete... more
https://www.medscape.com/answers/404450-181731/2007140-overview
Ovarian cancerOvarian cancer
Mucinous tumors include mucinous adenocarcinoma and mucinous cystadenocarcinoma. Mucinous adenocarcinomas make up 5-10% of ... It includes serous tumor, endometrioid tumor, and mucinous cystadenocarcinoma. Less common tumors are malignant Endometrioid ... Advanced mucinous adenocarcinomas have a poor prognosis, generally worse than serous tumors, and are often resistant to ... Estrogen HRT with or without progestins increases the risk of endometrioid and serous tumors but lowers the risk of mucinous ...
https://en.wikipedia.org/wiki/Ovarian_cancer
Pseudomyxoma peritoneiPseudomyxoma peritonei
... several mucinous tumors (mucinous adenocarcinoma, mucinous cystadenoma, and mucinous cystadenocarcinoma), as well as other ... Low-grade mucinous adenocarcinoma is used by the American Joint Committee on Cancer and World Health Organization and is nearly ... The term mucinous adenocarcinoma is used in different contexts depending on the reference material used by the pathologist for ... For low-grade mucinous adenocarcinoma, disease may be designated as "benign" because tumors do not invade deeply into tissue ...
https://en.wikipedia.org/wiki/Pseudomyxoma_peritonei
List of MeSH codes (C04)List of MeSH codes (C04)
... cystadenocarcinoma, mucinous MeSH C04.557.470.200.025.480.230 - cystadenocarcinoma, papillary MeSH C04.557.470.200.025.480.240 ... mucinous MeSH C04.557.470.590.480.230 - cystadenocarcinoma, papillary MeSH C04.557.470.590.480.240 - cystadenocarcinoma, serous ... mucinous, and serous MeSH C04.557.470.590.075 - adenocarcinoma, mucinous MeSH C04.557.470.590.340 - carcinoma, mucoepidermoid ... mucinous MeSH C04.557.470.035.320.230 - cystadenoma, papillary MeSH C04.557.470.035.320.240 - cystadenoma, serous MeSH C04.557. ...
https://en.wikipedia.org/wiki/List_of_MeSH_codes_(C04)
Salivary gland tumourSalivary gland tumour
Sebaceous carcinoma Sebaceous lymphadenocarcinoma Cystadenocarcinoma Low-grade cribriform cystadenocarcinoma Mucinous ...
https://en.wikipedia.org/wiki/Salivary_gland_tumour
PancreatectomyPancreatectomy
... mucinous/serous) Cystadenocarcinoma Islet cell tumors (neuroendocrine tumors) Papillary cystic neoplasms Lymphoma Acinar cell ...
https://en.wikipedia.org/wiki/Pancreatectomy
Testicular cancerTesticular cancer
... borderline malignancy Serous carcinoma Well differentiated endometrioid tumor Mucinous cystadenoma Mucinous cystadenocarcinoma ...
https://en.wikipedia.org/wiki/Testicular_cancer
CystadenomaCystadenoma
Endometrioid cystadenoma (8380) Appendix: The term mucinous cystadenoma is an obsolete term for appendiceal mucinous neoplasm ... When malignant, it is called cystadenocarcinoma. When not otherwise specified, the ICD-O coding is 8440/0. However, the ... "Appendix - Other tumors - Mucinous neoplasms (LAMN and HAMN)". Topic Completed: 1 October 2017. Revised: 11 December 2019 ... ISBN 978-1-4160-2999-1. Serous cystadenoma of pancreas at eMedicine Biliary cystadenoma/cystadenocarcinoma at eMedicine v t e. ...
https://en.wikipedia.org/wiki/Cystadenoma
Cystic lesions of the pancreasCystic lesions of the pancreas
Pancreatic mucinous cystadenoma Pancreatic mucinous cystadenocarcinoma Parra-Herran, C. E.; Garcia, M. T.; Herrera, L; Bejarano ... Pancreatic serous cystadenoma Pancreatic serous cystadenocarcinoma Pancreatic mucinous cystic tumors (13.4%) ... Pancreatic intraductal papillary mucinous tumors (most common diagnosis - 52.6%) Pancreatic serous cystic tumors (20.6%) ... Among this heterogeneous group, benign neoplasms predominate, particularly those with mucinous lining. Age at presentation, ...
https://en.wikipedia.org/wiki/Cystic_lesions_of_the_pancreas
CystadenocarcinomaCystadenocarcinoma
... mucinous cystadenomcarcinoma. Among the ovarian tumours, serous tumours are most common, having a variegated appearance. ... Bilateral presentation is common with serous cystadenocarcinoma. Papillary serous cystadenocarcinoma Ovarian serous cystadenoma ... Cystadenocarcinoma is a malignant form of a cystadenoma and is a cancer derived from glandular epithelium, in which cystic ... A cystadenocarcinoma contains complex multi-loculated cyst but with exuberant solid areas in places. It usually presents with ...
https://en.wikipedia.org/wiki/Cystadenocarcinoma
Mucinous cystadenomaMucinous cystadenoma
Biliary cystadenoma and cystadenocarcinoma constitute less than 5% of intrahepatic cysts originating from the bile duct. ... ovarian mucinous cystadenoma Pancreas-pancreatic mucinous cystadenoma Peritoneum-peritoneal mucinous cystadenoma Liver-mucinous ... Pancreatic Mucinous Cystadenoma or Mucinous Cystadenoma of the pancreas (MCN) are a type of mucinous cystic neoplasm of the ... Mucinous cystadenoma is a benign cystic tumor lined by a mucinous epithelium. It is a type of cystic adenoma (cystadenoma). ...
https://en.wikipedia.org/wiki/Mucinous_cystadenoma
Mucinous cystadenocarcinomaMucinous cystadenocarcinoma
... is a type of tumor in the cystadenocarcinoma grouping. It can occur in the breast as well as in the ... Honma N, Sakamoto G, Ikenaga M, Kuroiwa K, Younes M, Takubo K (August 2003). "Mucinous cystadenocarcinoma of the breast: a case ... radiopaedia.org/articles/mucinous-cystadenocarcinoma-of-ovary v t e. ...
https://en.wikipedia.org/wiki/Mucinous_cystadenocarcinoma
Mucinous cystadenocarcinoma of the lungMucinous cystadenocarcinoma of the lung
... mucinous bronchioloalveolar carcinoma, signet ring cell adenocarcinoma, mucinous cystadenocarcinoma, and mucinous "colloid" ... may be of use in differentiating primary mucinous cystadenocarcinoma of the lung from metastatic lung tumors due to mucinous ... Mucinous cystadenocarcinoma of the lung (MCACL) is a very rare malignant mucus-producing neoplasm arising from the uncontrolled ... Butnor KJ, Sporn TA, Dodd LG (2001). "Fine needle aspiration cytology of mucinous cystadenocarcinoma of the lung: report of a ...
https://en.wikipedia.org/wiki/Mucinous_cystadenocarcinoma_of_the_lung
Pancreatic serous cystadenomaPancreatic serous cystadenoma
... such as the intraductal papillary mucinous neoplasm and the mucinous cystic neoplasm), serous cystic neoplasms are almost ... "serous cystadenocarcinoma".[citation needed] These lesions rarely require surgery unless they are symptomatic or the diagnosis ... Ovarian serous cystadenoma Pancreatic mucinous cystadenoma Solid pseudopapillary neoplasm Jais, B; Rebours, V; Malleo, G; ...
https://en.wikipedia.org/wiki/Pancreatic_serous_cystadenoma
OvaryOvary
Mucinous cystadenocarcinoma Brenner tumor Granulosa cell tumor Krukenberg tumor Society and culture[edit]. Cryopreservation[ ...
https://en.wikipedia.org/wiki/Ovary
ProlactinomaProlactinoma
Mucinous. *Signet ring cell carcinoma *Krukenberg tumor. *Mucinous cystadenoma / Mucinous cystadenocarcinoma *Pseudomyxoma ...
https://en.wikipedia.org/wiki/Prolactinoma
Hepatocellular adenomaHepatocellular adenoma
Mucinous. *Signet ring cell carcinoma *Krukenberg tumor. *Mucinous cystadenoma / Mucinous cystadenocarcinoma *Pseudomyxoma ...
https://en.wikipedia.org/wiki/Hepatocellular_adenoma
Multiple endocrine neoplasiaMultiple endocrine neoplasia
Mucinous. *Signet ring cell carcinoma *Krukenberg tumor. *Mucinous cystadenoma / Mucinous cystadenocarcinoma *Pseudomyxoma ...
https://en.wikipedia.org/wiki/Multiple_endocrine_neoplasia
Non-small-cell lung carcinomaNon-small-cell lung carcinoma
Adenocarcinoma (Mucinous cystadenocarcinoma). *Large-cell lung carcinoma. *Rhabdoid carcinoma. *Sarcomatoid carcinoma. * ...
https://en.wikipedia.org/wiki/Non-small-cell_lung_carcinoma
Lung cancerLung cancer
Adenocarcinoma (Mucinous cystadenocarcinoma). *Large-cell lung carcinoma. *Rhabdoid carcinoma. *Sarcomatoid carcinoma. * ...
https://en.wikipedia.org/wiki/Lung_cancer
Targeted therapy of lung cancerTargeted therapy of lung cancer
Adenocarcinoma (Mucinous cystadenocarcinoma). *Large-cell lung carcinoma. *Rhabdoid carcinoma. *Sarcomatoid carcinoma. * ... Several studies have shown that EGFR-TKI's are particularly active in papillary and non-mucinous bronchioloalveolar carcinoma ... non-mucinous bronchioloalveolar carcinoma,[29] and adenocarcinoma with mixed subtypes.[28] ...
https://en.wikipedia.org/wiki/Targeted_therapy_of_lung_cancer
Typical pulmonary carcinoid tumourTypical pulmonary carcinoid tumour
Adenocarcinoma (Mucinous cystadenocarcinoma). *Large-cell lung carcinoma. *Rhabdoid carcinoma. *Sarcomatoid carcinoma. * ...
https://en.wikipedia.org/wiki/Typical_pulmonary_carcinoid_tumour
Template:Respiratory neoplasiaTemplate:Respiratory neoplasia
Adenocarcinoma (Mucinous cystadenocarcinoma). *Large-cell lung carcinoma. *Rhabdoid carcinoma. *Sarcomatoid carcinoma. * ...
https://en.wikipedia.org/wiki/Template:Respiratory_neoplasia
Linitis plasticaLinitis plastica
Mucinous. *Signet ring cell carcinoma *Krukenberg tumor. *Mucinous cystadenoma / Mucinous cystadenocarcinoma *Pseudomyxoma ...
https://en.wikipedia.org/wiki/Linitis_plastica
Surface epithelial-stromal tumorSurface epithelial-stromal tumor
As primary ovarian mucinous tumors are usually unilateral (in one ovary), the presentation of bilateral mucinous tumors ... 75% are benign or of borderline malignancy, and 25% are malignant The malignant form of this tumor, serous cystadenocarcinoma, ... of primary mucinous tumors are bilateral. May form very large cystic masses, with recorded weights exceeding 25 kg Mucinous ... Mucinous tumors: Closely resemble their serous counterparts but unlikely to be bilateral Somewhat less common, accounting for ...
https://en.wikipedia.org/wiki/Surface_epithelial-stromal_tumor
AdenomyomaAdenomyoma
Mucinous cystadenoma. *Cystadenocarcinoma *Papillary serous cystadenocarcinoma. *Krukenberg tumor. *Endometrioid tumor. *Clear- ...
https://en.wikipedia.org/wiki/Adenomyoma
Sarcoma botryoidesSarcoma botryoides
Mucinous cystadenoma. *Cystadenocarcinoma *Papillary serous cystadenocarcinoma. *Krukenberg tumor. *Endometrioid tumor. *Clear- ...
https://en.wikipedia.org/wiki/Sarcoma_botryoides
Granulosa cell tumourGranulosa cell tumour
Mucinous cystadenoma. *Cystadenocarcinoma *Papillary serous cystadenocarcinoma. *Krukenberg tumor. *Endometrioid tumor. *Clear- ...
https://en.wikipedia.org/wiki/Granulosa_cell_tumour
印戒细胞癌 - 维基百科，自由的百科全印戒细胞癌 - 维基百科，自由的百科全
粘液性囊腺瘤 / Mucinous cystadenocarcinoma（英语：Mucinous cystadenocarcinoma） *Pseudomyxoma peritonei（英语：Pseudomyxoma peritonei） ... 印戒细胞癌（Signet ring cell carcinoma，SRCC），又称黏液细胞癌（mucinous cell carcinoma，MCC）是上皮组织的恶性肿瘤，组织学外观特点是可以见到印戒细胞。 ... 卵巢浆液性囊腺瘤 / Pancreatic
https://zh.wikipedia.org/wiki/印戒细胞癌
肺癌 - 维基百科，自由的百科全书肺癌 - 维基百科，自由的百科全书
肺腺癌（黏液性囊腺癌（英语：Mucinous cystadenocarcinoma of the lung）） ...
https://zh.wikipedia.org/wiki/肺癌
International Classification of Diseases for OncologyInternational Classification of Diseases for Oncology
M8470/2 Mucinous cystadenocarcinoma, non-invasive (C25._) M8470/3 Mucinous cystadenocarcinoma/ NOS (C56.9) Pseudomucinous ... NOS M8471/3 papillary mucinous cystadenocarcinoma (C56.9) Papillary pseudomucinous cystadenocarcinoma M8472/1 Mucinous cystic ... Papillary mucinous tumor of low malignant potential M8480/0 Mucinous adenoma M8480/3 Mucinous adenocarcinoma Mucinous carcinoma ... M9015/3 Mucinous adenocarcinofibroma Malignant mucinous adenofibroma Mucinous cystadenocarcinofibroma Malignant mucinous ...
https://en.wikipedia.org/wiki/International_Classification_of_Diseases_for_Oncology
CarcinoidCarcinoid
Mucinous. *Signet ring cell carcinoma *Krukenberg tumor. *Mucinous cystadenoma / Mucinous cystadenocarcinoma *Pseudomyxoma ...
https://en.wikipedia.org/wiki/Gastrointestinal_carcinoid_tumor
Mucinous cystadenocarcinoma - WikipediaMucinous cystadenocarcinoma - Wikipedia
Mucinous cystadenocarcinoma is a type of tumor in the cystadenocarcinoma grouping. It can occur in the breast as well as in the ... Honma N, Sakamoto G, Ikenaga M, Kuroiwa K, Younes M, Takubo K (August 2003). "Mucinous cystadenocarcinoma of the breast: a case ... radiopaedia.org/articles/mucinous-cystadenocarcinoma-of-ovary v t e. ...
https://en.wikipedia.org/wiki/Mucinous_cystadenocarcinoma
Mucinous Cystadenocarcinoma, Appendix | SpringerLinkMucinous Cystadenocarcinoma, Appendix | SpringerLink
Well-differentiated mucinous adenocarcinoma An appendiceal adenocarcinoma is a malignant epithelial neoplasm of the appendix ... Macroscopically, mucinous adenocarcinomas of the appendix can be cystic or not. The term "mucinous cystadenocarcinoma" may be ... Svrcek M. (2017) Mucinous Cystadenocarcinoma, Appendix. In: Carneiro F., Chaves P., Ensari A. (eds) Pathology of the ... appendiceal adenocarcinomas are separated into mucinous and non-mucinous types (UICC/AJCC TNM staging 2010). Indeed, the 5-year ...
https://link.springer.com/referenceworkentry/10.1007/978-3-319-40560-5_1512
Mucinous cystadenocarcinoma of the lung - WikipediaMucinous cystadenocarcinoma of the lung - Wikipedia
... mucinous bronchioloalveolar carcinoma, signet ring cell adenocarcinoma, mucinous cystadenocarcinoma, and mucinous "colloid" ... may be of use in differentiating primary mucinous cystadenocarcinoma of the lung from metastatic lung tumors due to mucinous ... Mucinous cystadenocarcinoma of the lung (MCACL) is a very rare malignant mucus-producing neoplasm arising from the uncontrolled ... Butnor KJ, Sporn TA, Dodd LG (2001). "Fine needle aspiration cytology of mucinous cystadenocarcinoma of the lung: report of a ...
https://en.wikipedia.org/wiki/Mucinous_cystadenocarcinoma_of_the_lung
An extremely rare cause of acute abdomen in pregnancy: ruptured pancreatic mucinous cystadenocarcinoma.An extremely rare cause of acute abdomen in pregnancy: ruptured pancreatic mucinous cystadenocarcinoma.
To our knowledge, there have been 2 published cases of pancreatic mucinous cystadenocarcinoma (PMC) during pregnancy in the ... Pancreatic cystadenocarcinoma is an extremely rare neoplasm in pregnancy. ... Previous Document: Mucinous cystadenocarcinoma of the pancreas during pregnancy.. Next Document: Triterpenoids and rexinoids as ... Cystadenocarcinoma, Mucinous / complications, diagnosis*, pathology. Female. Humans. Live Birth. Pancreatic Neoplasms / ...
http://www.biomedsearch.com/nih/extremely-rare-cause-acute-abdomen/17446849.html
Proliferative Brenner Tumor with Borderline Mucinous Cystadenocarcinoma of the Ovary in a 75-Year-Old WomanProliferative Brenner Tumor with Borderline Mucinous Cystadenocarcinoma of the Ovary in a 75-Year-Old Woman
Histopathological examination revealed proliferative Brenner ovarian tumor with borderline mucinous cystadenocarcinoma, and ... We report here an extremely rare case of proliferative Brenner tumor with borderline mucinous cystadenocarcinoma of the ovary, ... We report here an extremely rare case of proliferative Brenner tumor with borderline mucinous cystadenocarcinoma of the ovary, ... Proliferative Brenner Tumor with Borderline Mucinous Cystadenocarcinoma of the Ovary in a 75-Year-Old Woman ...
https://www.scirp.org/journal/PaperInformation.aspx?PaperID=45118
Autophagy promotes malignant migration and invasion via miR‑224‑5p/BCL2 in pancreatic mucinous cystadenocarcinoma MCC1 cellsAutophagy promotes malignant migration and invasion via miR‑224‑5p/BCL2 in pancreatic mucinous cystadenocarcinoma MCC1 cells
Invasive mucinous cystadenocarcinoma of the pancreas. Pancreatic body and tail. 4. Female. 62. Pancreatic mucinous cystic tumor ... Clinicopathological data of four cases of pancreatic mucinous cystadenocarcinoma.. Patient number. Sex. Age (years). ... Invasive mucinous cystadenocarcinoma of the pancreas. Pancreatic body and tail. 0/1. ... Pancreatic mucinous cystadenoma and cystadenocarcinoma are different stages of tumor progression. However, autophagy serves an ...
https://www.spandidos-publications.com/10.3892/ol.2020.12139
Osteopathic Approach to the Diagnosis of Appendiceal Mucinous Cystadenocarcinoma Mimicking Primary Ovarian Malignant Neoplasm |...Osteopathic Approach to the Diagnosis of Appendiceal Mucinous Cystadenocarcinoma Mimicking Primary Ovarian Malignant Neoplasm |...
Osteopathic Approach to the Diagnosis of Appendiceal Mucinous Cystadenocarcinoma Mimicking Primary Ovarian Malignant Neoplasm. ... Osteopathic Approach to the Diagnosis of Appendiceal Mucinous Cystadenocarcinoma Mimicking Primary Ovarian Malignant Neoplasm ... Osteopathic Approach to the Diagnosis of Appendiceal Mucinous Cystadenocarcinoma Mimicking Primary Ovarian Malignant Neoplasm ... To our knowledge, preoperative diagnosis has only been reported with the mucinous histologic subtype.3 Mucinous ...
http://jaoa.org/article.aspx?articleid=2531569
Mucinous cystadenoma and cystadenocarcinoma of the vermiform appendix with particular reference to mucocele and pseudomyxoma...Mucinous cystadenoma and cystadenocarcinoma of the vermiform appendix with particular reference to mucocele and pseudomyxoma...
Mucinous cystadenoma and cystadenocarcinoma of the vermiform appendix with particular reference to mucocele and pseudomyxoma ... Mucinous cystadenoma and cystadenocarcinoma of the vermiform appendix with particular reference to mucocele and pseudomyxoma ...
https://jcp.bmj.com/content/26/6/413.altmetrics
Mucinous cystadenoma and cystadenocarcinoma of the vermiform appendix with particular reference to mucocele and pseudomyxoma...Mucinous cystadenoma and cystadenocarcinoma of the vermiform appendix with particular reference to mucocele and pseudomyxoma...
Mucinous cystadenoma and cystadenocarcinoma of the vermiform appendix with particular reference to mucocele and pseudomyxoma ... Mucinous cystadenoma and cystadenocarcinoma of the vermiform appendix with particular reference to mucocele and pseudomyxoma ... Two cases were of mucinous cystadenocarcinoma and one of these was diagnosed as `pseudomyxoma peritonei. `Pseudomyxoma ... is a misnomer and is caused by dissemination of a mucinous cystadenocarcinoma within the peritoneal cavity. The special ...
https://jcp.bmj.com/content/26/6/413
Primary mucinous cystadenocarcinoma of the renal pelvis misdiagnosed as ureteropelvic junction stenosis with renal pelvis stone...Primary mucinous cystadenocarcinoma of the renal pelvis misdiagnosed as ureteropelvic junction stenosis with renal pelvis stone...
Primary mucinous cystadenocarcinoma of the renal pelvis misdiagnosed as ureteropelvic junction stenosis with renal pelvis stone ... Mucinous cystadenocarcinoma of the renal pelvis: a case report and clues to histogenesis. Bmj Case Reports 2009: -, 2009 ... Primary mucinous cystadenocarcinoma of renal pelvis: a case report. Cases Journal 2(): 9395-9395, 2010 ... Primary mucinous cystadenocarcinoma of the renal pelvis misdiagnosed as ureteropelvic junction stenosis with renal pelvis stone ...
https://eurekamag.com/research/058/625/058625394.php
openarchives.gr | Mucinous cystadenocarcinoma of the pancreas - outcome following different modes of treatmentopenarchives.gr | Mucinous cystadenocarcinoma of the pancreas - outcome following different modes of treatment
Mucinous cystadenocarcinomas (MCAC) of the pancreas are rare tumours, when localised to the pancreas alone, surgical resection ... Mucinous cystadenocarcinoma of the pancreas - outcome following different modes of treatment (EN) ... Mucinous cystadenocarcinoma of the pancreas - outcome following different modes of treatment URI: https://www.openarchives.gr/ ... Aim of the study: Mucinous cystadenocarcinomas (MCAC) of the pancreas are rare tumours, when localised to the pancreas alone, ...
https://www.openarchives.gr/aggregator-openarchives/edm/gastro/000025-article_view_904?language=en
Chemotherapy Help - Forums and Discussions - MedHelp - Page 2Chemotherapy Help - Forums and Discussions - MedHelp - Page 2
I have mucinous cystadenocarcinoma found at stage 3B/C in June of 2007. P... ...
https://www.medhelp.org/forums/Chemotherapy/show/348?page=2
Mucinous cystadenoma and cystadenocarcinoma - Herb Kosten FoundationMucinous cystadenoma and cystadenocarcinoma - Herb Kosten Foundation
Mucinous cystadenoma and cystadenocarcinoma. Written by Kosten Foundation on June 8, 2017. . Posted in Definitions, ... Mucinous cystadenoma is a type of cystic neoplasm. This type of tumor is usually benign when small but can grow and degenerate ... Even if a cystadenocarcinoma is found, the prognosis is quite good if the tumor can be surgically removed. ...
https://www.kostenfoundation.com/mucinous-cystadenoma-and-cystadenocarcinoma/
Mucinous cystadenocarcinoma ovary presented as giant pelvic abdominal Mass Mucinous cystadenocarcinoma ovary presented as giant pelvic abdominal Mass
Mucinous cystadenocarcinoma ovary presented as giant pelvic abdominal Mass Jagtap, Sunil 관련메뉴. Dhawan, Shrutika 관련메뉴. Jagtap, ...
http://www.ndsl.kr/ndsl/search/detail/article/articleSearchResultDetail.do?cn=NART82058183
Papillary mucinous cystadenocarcinoma: rare malignant tumor in minor salivary glandPapillary mucinous cystadenocarcinoma: rare malignant tumor in minor salivary gland
... was diagnosed as papillary mucinous papillary mucinous cystadenocarcinoma. Nonetheless, the cellular atypia found was ... Papillary mucinous cystadenocarcinoma can be histologically described by the presence of large cystic spaces filled with mucus ... In the case of papillary mucinous cystadenocarcinoma, the highest prevalence occurs in adults, with a mean age of 58.8 years ... Clinical case description of a papillary mucinous cystadenocarcinoma, extremely rare malignant tumor in the salivary gland and ...
http://revodonto.bvsalud.org/scielo.php?script=sci_arttext&pid=S1981-86372016000200013
Papillary mucinous cystadenocarcinoma: rare malignant tumor in minor salivary glandPapillary mucinous cystadenocarcinoma: rare malignant tumor in minor salivary gland
MARIANO, Ronaldo Célio et al. Papillary mucinous cystadenocarcinoma: rare malignant tumor in minor salivary gland. RGO, Rev. ... was diagnosed as papillary mucinous papillary mucinous cystadenocarcinoma. Nonetheless, the cellular atypia found was ... Clinical case description of a papillary mucinous cystadenocarcinoma, extremely rare malignant tumor in the salivary gland and ...
http://revodonto.bvsalud.org/scielo.php?script=sci_abstract&pid=S1981-86372016000200013&lng=en&nrm=iso&tlng=en
Clinical Evidence for Adenoma-Carcinoma Sequence in Primary Retroperitoneal Mucinous CystadenocarcinomaClinical Evidence for Adenoma-Carcinoma Sequence in Primary Retroperitoneal Mucinous Cystadenocarcinoma
... PubMed, SCI, Scopus, ... mucinous borderline tumors, and mucinous cystadenocarcinomas. In the ovary, benign mucinous epithelia and/or mucinous ... These findings strongly suggest that mucinous cystadenocarcinoma arose from the pre-existing benign mucinous cystadenoma. This ... Conclusion: Primary retroperitoneal mucinous cystadenocarcinoma could arise from the pre-existing benign mucinous cystadenoma. ...
https://fortunejournals.com/articles/clinical-evidence-for-adenomacarcinoma-sequence-in-primary-retroperitoneal-mucinous-cystadenocarcinoma.html
appendiceal mucinous cystadenocarcinoma 2005:2010[pubdate] *count=100 - BioMedLib™ search engineappendiceal mucinous cystadenocarcinoma 2005:2010[pubdate] *count=100 - BioMedLib™ search engine
Cystadenocarcinoma, Mucinous / epidemiology. Cystadenocarcinoma, Mucinous / pathology. Cystadenocarcinoma, Mucinous / surgery. ... Cystadenocarcinoma, Mucinous / complications. Cystadenocarcinoma, Mucinous / surgery. Cystadenoma, Mucinous / complications. ... Cystadenocarcinoma, Mucinous / pathology. Cystadenocarcinoma, Mucinous / surgery. Cystadenoma, Mucinous / pathology. ... Mucinous lesions (mucocele) are classified as mucosal hyperplasia, mucinous cystadenoma, or mucinous cystadenocarcinoma. ...
http://www.bmlsearch.com/?kwr=appendiceal+mucinous+cystadenocarcinoma+2005:2010%5Bpubdate%5D&cxts=100&stmp=b0
mucinous cystadenocarcinoma ovary drug therapy 2000:2010[pubdate] *count=100 - BioMedLib™ search enginemucinous cystadenocarcinoma ovary drug therapy 2000:2010[pubdate] *count=100 - BioMedLib™ search engine
Cystadenocarcinoma, Mucinous / drug therapy. Cystadenocarcinoma, Mucinous / genetics. Cystadenocarcinoma, Mucinous / metabolism ... Cystadenocarcinoma, Mucinous / drug therapy. Cystadenocarcinoma, Mucinous / metabolism. Cystadenocarcinoma, Mucinous / ... Cystadenocarcinoma, Mucinous / pathology. Cystadenocarcinoma, Mucinous / secondary. Cystadenocarcinoma, Mucinous / surgery. ... Cystadenocarcinoma, Mucinous / drug therapy. Cystadenocarcinoma, Mucinous / surgery. Disease Progression. Female. Humans. ...
http://www.bmlsearch.com/?kwr=mucinous+cystadenocarcinoma+ovary+drug+therapy+2000:2010%5Bpubdate%5D&cxts=100&stmp=b1
March-April 1999 - Volume 6 - Issue 2 : Advances in Anatomic PathologyMarch-April 1999 - Volume 6 - Issue 2 : Advances in Anatomic Pathology
Mucinous cystadenocarcinoma-a rare subtype of mammary carcinoma. Less Advances in Anatomic Pathology. 6(2):121, March-April ... Pancreatic Neoplasms with Abundant Mucus Production: Emphasis on Intraductal Papillary-Mucinous Tumors and Mucinous Cystic ...
https://journals.lww.com/anatomicpathology/toc/1999/03000
Pulmonary Mucinous Cystadenocarcinoma: Report of a Case and Review of the Literature<...Pulmonary Mucinous Cystadenocarcinoma: Report of a Case and Review of the Literature<...
Pulmonary Mucinous Cystadenocarcinoma: Report of a Case and Review of the Literature. Annals of Thoracic Surgery. 2003 Jan 1;76 ... Pulmonary Mucinous Cystadenocarcinoma : Report of a Case and Review of the Literature. In: Annals of Thoracic Surgery. 2003 ; ... A case of primary mucinous cystadenocarcinoma of the lung is presented. The patient was a 42-year-old woman with a 5-cm left ... Pulmonary Mucinous Cystadenocarcinoma : Report of a Case and Review of the Literature. / Ishibashi, Hironori; Moriya, Takuya; ...
https://pure.fujita-hu.ac.jp/en/publications/pulmonary-mucinous-cystadenocarcinoma-report-of-a-case-and-review
Familial association of specific histologic types of ovarian malignancy with other malignancies - Bermejo - 2004 - Cancer -...Familial association of specific histologic types of ovarian malignancy with other malignancies - Bermejo - 2004 - Cancer -...
papillary serous cystadenocarcinoma; *endometrioid carcinoma; *mucinous cystadenocarcinoma; *serous carcinoma; *clear cell ... Ma-Lee Ko, Hun-Shan Pan, Identical twins with ovarian endometriosis and mucinous borderline tumor: an unusual association, ... papillary serous cystadenocarcinoma was found to be associated with ovarian and skin malignancies and with myeloma; and ... risk of developing endometrioid carcinoma was slightly greater than the risk of developing papillary serous cystadenocarcinoma. ...
http://onlinelibrary.wiley.com/doi/10.1002/cncr.20138/abstract
Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm - Full Text View -...Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm - Full Text View -...
Mucinous Cystic Tumor With Moderate Dysplasia Mucinous Cystadenoma of Pancreas Mucinous Cystadenocarcinoma of Pancreas Benign ... Cystadenocarcinoma. Cystadenocarcinoma, Mucinous. Neoplasms. Cystadenoma. Pancreatic Neoplasms. Cystadenoma, Mucinous. ... Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm. The safety and ... Neoplasms, Cystic, Mucinous, and Serous. Adenoma. Digestive System Neoplasms. Neoplasms by Site. Endocrine Gland Neoplasms. ...
https://clinicaltrials.gov/ct2/show/NCT01525706?cond=%22Adenocarcinoma+of+the+appendix%22&rank=18
The long-term survival in primary retroperitoneal mucinous cystadenocarcinoma: a case report | Surgical Case Reports | Full TextThe long-term survival in primary retroperitoneal mucinous cystadenocarcinoma: a case report | Surgical Case Reports | Full Text
RetroperitonealCystadenocarcinomaMucinous. Background. Primary retroperitoneal mucinous cystadenocarcinoma (PRMC) is extremely ... Primary retroperitoneal mucinous cystadenocarcinoma in a male patient: a case report. Cases J. 2009;2:7196.View ArticlePubMed ... Mucinous cystadenocarcinoma of the retroperitoneum: report of a case. Surg Today. 2001;31:747-50.View ArticlePubMedGoogle ... Primary retroperitoneal mucinous cystadenocarcinoma: report of two cases. World J Surg Oncol. 2007;5:5.View ArticlePubMedPubMed ...
https://surgicalcasereports.springeropen.com/articles/10.1186/s40792-017-0394-z
Objective Mucinous cystadenocarcinoma of appendix is certainly a uncommon entity. microarray - Small-Molecule Inhibitors of...Objective Mucinous cystadenocarcinoma of appendix is certainly a uncommon entity. microarray - Small-Molecule Inhibitors of...
Objective Mucinous cystadenocarcinoma of appendix is certainly a uncommon entity. microarray. Posted on September 7, 2019. ... was considerably down controlled in mucinous cystadenocarcinoma set alongside the mucinous cystadenoma (p 0.05). Alternatively ... In six cases of mucinous cystadenocarcinoma, the male to female ratio was 1:5 and the median age group was 65 years of age with ... Objective Mucinous cystadenocarcinoma of appendix is certainly a uncommon entity. microarray manifestation profiling from ...
http://www.conferencecallsworld.com/2019/09/07/objective-mucinous-cystadenocarcinoma-of-appendix-is-certainly-a-uncommon-entity-microarray/
July-August 1999 - Volume 23 - Issue 4 : Journal of Computer Assisted TomographyJuly-August 1999 - Volume 23 - Issue 4 : Journal of Computer Assisted Tomography
Mucinous Cystadenocarcinoma of the Lung: CT-Pathologic Correlation in Three Cases. Gaeta, Michele; Blandino, Alfredo; Scribano ...
https://journals.lww.com/jcat/toc/1999/07000
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene - Full Text...Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene - Full Text...
Adenocarcinoma, Mucinous. Cystadenocarcinoma. Laryngeal Neoplasms. Urologic Neoplasms. Mouth Neoplasms. Lip Neoplasms. ... Mucinous Adenocarcinoma Gastric Mucinous Breast Cancer Recurrent Cholangiocarcinoma Drug: A166 Phase 1 Phase 2 ...
https://www.clinicaltrials.gov/ct2/show/NCT03602079
Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary...Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary...
Cystadenocarcinoma, Serous. Adenocarcinoma, Mucinous. Cystadenocarcinoma. Adenocarcinoma, Clear Cell. Neoplasms by Histologic ... Neoplasms, Cystic, Mucinous, and Serous. Bevacizumab. Pembrolizumab. Cyclophosphamide. Endothelial Growth Factors. Antibodies. ... Fallopian Tube Clear Cell Adenocarcinoma Fallopian Tube Endometrioid Adenocarcinoma Fallopian Tube Mucinous Adenocarcinoma ... Participant may have serous, endometrioid, clear cell, mucinous or undifferentiated type of recurrent epithelial ovarian, ...
https://www.clinicaltrials.gov/ct2/show/NCT02853318
Epidermal Growth Factor and Intestinal Barrier FunctionEpidermal Growth Factor and Intestinal Barrier Function
4Mucinous cystadenocarcinoma. 5Serous cystadenocarcinoma. 6Darby canine kidney cells.. Table 2 ...
https://www.hindawi.com/journals/mi/2016/1927348/
A Case Report of Partial Nephrectomy of Mucinous Cystadenocarcinoma in Kidney and Its Literature Review | Cancer Research and...A Case Report of Partial Nephrectomy of Mucinous Cystadenocarcinoma in Kidney and Its Literature Review | Cancer Research and...
Mucinous cystadenocarcinoma (MC) of the kidney is a rare epithelial tumor originating from the renal pelvic urothelium and few ... Cystadenocarcinoma, Mucinous , Diagnosis , Gastroenterology , Humans , Kidney , Liver , Middle Aged , Mucins , Nephrectomy , ... A Case Report of Partial Nephrectomy of Mucinous Cystadenocarcinoma in Kidney and Its Literature Review / Journal of the Korean ... A Case Report of Partial Nephrectomy of Mucinous Cystadenocarcinoma in Kidney and Its Lite ...
https://search.bvsalud.org/gim/resource/en/wpr-26776
CarcinomaTumorNeoplasmAppendixOvaryPancreasDiagnosisMalignant mucinousAppendiceal mucinousCystEpithelialPancreatic mucinous cystadenocarcinomaBiliary cystadenomaMucinLesionsBenignSerous cystadenomaMucoceleHistologicalColumnarPseudomyxomaCase of pancreaticIPMNLungCystadenomasNeuroendocrinePrognosisClinical
Carcinoma18
  • However, the distinction between a cystic carcinoma (i.e., cystadenocarcinoma) and one that is not cystic has not been shown to be of biologic significance. (springer.com)
  • Informally, some experts have included these tumors as a distinct variant among a spectrum of mucus-producing adenocarcinomas, including - in order of increasing relative extent of cellular mucus production and extracellular mucus accumulation - solid adenocarcinoma, mucoepidermoid carcinoma, mucinous bronchioloalveolar carcinoma, signet ring cell adenocarcinoma, mucinous cystadenocarcinoma, and mucinous "colloid" adenocarcinoma. (wikipedia.org)
  • Microscopically, the neoplastic epithelial cells tend to grow along the alveolar walls, in a fashion similar to the mucinous variant of bronchioloalveolar carcinoma, a more common form of adenocarcinoma. (wikipedia.org)
  • Differential diagnosis of MCACL includes secondary metastatic cystadenocarcinomatous lesions, particularly from the pancreas or ovary, mucoepidermoid carcinoma, and pulmonary mucinous bronchioloalveolar carcinoma. (wikipedia.org)
  • Mucoepidermoid carcinoma, salivary duct carcinoma, and cystadenocarcinoma are part of this group of mucin-producing tumors, among others. (bvsalud.org)
  • Adenoma-borderline tumor-carcinoma sequence, which was substantiated in the pathogenesis of ovarian mucinous carcinoma, could be extrapolated to that of primary retroperitoneal mucinous cystadenocarcinoma. (fortunejournals.com)
  • In the ovary, benign mucinous epithelia and/or mucinous borderline tumors coexist in invasive primary ovarian mucinous carcinoma in majority of the cases [8, 9]. (fortunejournals.com)
  • These morphologic and genetic findings strongly support the idea that mucinous carcinomas arise from pre-existing benign and/or borderline mucinous tumors (i.e., adenoma?borderline tumor?carcinoma sequence). (fortunejournals.com)
  • Here, we present a case of primary retroperitoneal mucinous cystadenocarcinoma that could lend evidence for the presence of adenoma?borderline tumor?carcinoma sequence in primary retroperitoneal mucinous tumor. (fortunejournals.com)
  • The tumor we found is a very rare intrapulmonary neoplasm that is differentiated from a metastatic lesion and mucinous bronchoalveolar carcinoma by its very different clinical course and prognosis. (fujita-hu.ac.jp)
  • For younger women (ages 40-45 years) whose mothers were affected with endometrial malignancies, the risk of developing endometrioid carcinoma was slightly greater than the risk of developing papillary serous cystadenocarcinoma. (wiley.com)
  • A case of pancreatic heterotopy of duodenal wall, intraductal papillary mucinous tumor and intraepithelial neoplasm of pancreas, papillary carcinoma of kidney in a single patient. (biomedsearch.com)
  • Histopathologic analysis of the surgical specimen revealed mild differentiated papillary renal carcinoma, intraductal papillary mucinous adenoma of the pancreatic head, foci of intraepithelial pancreatic neoplasm and pancreatic heterotopy of duodenal muscular and submucosal layers. (biomedsearch.com)
  • Rare pancreatic tumors including acinar cell carcinoma, mucinous cystadenocarcinoma or serous cystadenocarcinoma. (cancer.gov)
  • For the mucinous carcinomas involving the remainder of the colon , please refer to the article on mucinous carcinoma of the colon . (radiopaedia.org)
  • Staging and management of these are different from those of colorectal carcinoma , please refer to the appendiceal mucinous neoplasms TNM staging for further details. (radiopaedia.org)
  • Journal Article] A case of Krukenberg carcinoma metastasized from colon cancer resembling mucinous cystadenocarcinoma of the ovary. (nii.ac.jp)
  • Granulosa cell tumors, primary ovarian carcinoma such as mucinous and serous cystadenocarcinoma, and undifferentiated adenocarcinoma were the most prevalent malignant masses. (news-medical.net)
Tumor19
  • Mucinous cystadenocarcinoma is a type of tumor in the cystadenocarcinoma grouping. (wikipedia.org)
  • We report here an extremely rare case of proliferative Brenner tumor with borderline mucinous cystadenocarcinoma of the ovary, metastasizing to the pleura in a 75-year-old woman. (scirp.org)
  • Histopathological examination revealed proliferative Brenner ovarian tumor with borderline mucinous cystadenocarcinoma, and immunohistochemical examinations for the tumors, even mucus-rich tumor cells were positive for CK 7 and negative for CK 20, suggesting the tumor arising from transitional cells, not from mucus-producing ovarian surface epithelial tumor cells. (scirp.org)
  • A total of 4 paired paraffin-embedded pancreatic mucinous cystadenocarcinoma samples and matched adjacent tissues were obtained retrospectively from the Department of Pathology, Changhai Hospital (Shanghai, China) ( Table I ). The distance between the tumor and the adjacent tissue sampling point site was 15 mm. (spandidos-publications.com)
  • Even if a cystadenocarcinoma is found, the prognosis is quite good if the tumor can be surgically removed. (kostenfoundation.com)
  • Clinical case description of a papillary mucinous cystadenocarcinoma, extremely rare malignant tumor in the salivary gland and difficult to diagnose, in geriatric patient. (bvsalud.org)
  • Since surface epithelium is not normally present in the retroperitoneum, primary retroperitoneal mucinous tumor is a rare disease. (fortunejournals.com)
  • Among them, the most favored is the last hypothesis, in which the mucinous tumor arises from invagination of the peritoneal mesothelial layer that undergoes mucinous metaplasia with cystic formation. (fortunejournals.com)
  • The tumor was a fibrous, walled cyst containing abundant mucinous material. (fujita-hu.ac.jp)
  • thus, the tumor resembled mucinous cystadenocarcinoma that occurs in the ovary, appendix, or pancreas. (fujita-hu.ac.jp)
  • The tumor was completely resected with a subsequent histopathological diagnosis of primary retroperitoneal mucinous cystadenocarcinoma (PRMC). (springeropen.com)
  • Dialogue The prognosis and treatment of the appendiceal mucinous neoplasm are significantly reliant on the medical diagnosis and classification from the tumor [11]. (conferencecallsworld.com)
  • Mucinous cystadenocarcinoma (MC) of the kidney is a rare epithelial tumor originating from the renal pelvic urothelium and few study cases have been reported. (bvsalud.org)
  • Primary mucinous cystadenocarcinoma (MCA) of the breast is a rare but pathologically distinct breast tumor . (bvsalud.org)
  • The subject of this report is a mural nodule with features of a low-grade endometrial stromal sarcoma (LGESS) with myxoid change arising in an ovarian mucinous borderline tumor. (springermedizin.de)
  • 1406 Collision Tumor of the Appendix: Mucinous Cystadenoma and Carcinoid. (enets.org)
  • Primary neuroendocrine tumor of ovary is an uncommon neoplasm that may be found as a solitary mass or in association with teratomas or mucinous tumors. (enets.org)
  • Pancreatic involvement is present in 35-70% of cases and include cystic (simple cyst, serous cystoadenoma, mucinous tumor or IPMN) and solid lesions (neuroendocrine neoplasm (NEN), metastatic mass or pancreatic adenocarcinoma). (enets.org)
  • mucinous cystic tumor of the pancreas. (scielo.org.co)
Neoplasm6
  • Mucinous cystadenocarcinoma of the lung (MCACL) is a very rare malignant mucus-producing neoplasm arising from the uncontrolled growth of transformed epithelial cells originating in lung tissue. (wikipedia.org)
  • Pancreatic cystadenocarcinoma is an extremely rare neoplasm in pregnancy. (biomedsearch.com)
  • Martingano D, Gurm H, Oliff A, Martingano FX, Aglialoro G. Osteopathic Approach to the Diagnosis of Appendiceal Mucinous Cystadenocarcinoma Mimicking Primary Ovarian Malignant Neoplasm. (jaoa.org)
  • Mucinous cystadenoma is a type of cystic neoplasm. (kostenfoundation.com)
  • These data claim that the miRNA manifestation in mucinous NVP-LDE225 biological activity appendiceal neoplasm can help to health supplement the morphological evaluation in distinguishing harmless from malignant tumors. (conferencecallsworld.com)
  • Cystadenocarcinoma ( papillary cystadenocarcinoma ) of the salivary gland is a rare malignant neoplasm. (labome.org)
Appendix17
  • Macroscopically, mucinous adenocarcinomas of the appendix can be cystic or not. (springer.com)
  • Svrcek M. (2017) Mucinous Cystadenocarcinoma, Appendix. (springer.com)
  • Eight cases were of mucinous cystadenoma of the appendix and six cases showed acute inflammation. (bmj.com)
  • Objective Mucinous cystadenocarcinoma of appendix is certainly a uncommon entity. (conferencecallsworld.com)
  • A case of mucinous cystadenocarcinoma of the appendix with abdominal wall abscess successfully treated by percutaneous drainage and systemic chemotherapy-a case report]. (elsevier.com)
  • A 76-year-old woman was diagnosed of mucinous cystadenocarcinoma of the appendix. (elsevier.com)
  • We report a rare case of the conservative therapy of mucinous cystadenocarcinoma of appendix with abdominal wall abscess. (elsevier.com)
  • Fingerprint Dive into the research topics of '[A case of mucinous cystadenocarcinoma of the appendix with abdominal wall abscess successfully treated by percutaneous drainage and systemic chemotherapy-a case report]. (elsevier.com)
  • The histological diagnosis was mucinous adenocarcinoma of the vermiform appendix, and the stage was T4NxM1. (hindawi.com)
  • Fibromixoma and low grade mucinous adenocarcinoma (pseudomixoma peritonei) of the appendix and ovary (closed to accrual 03 / 20 / 2018) 8. (cancer.gov)
  • Mucinous adenocarcinomas of the appendix are on the malignant end of the spectrum of the mucinous neoplasms that affect the caecal appendix . (radiopaedia.org)
  • Considerable controversy still exists on mucinous neoplasms of the appendix pathologic classification and nomenclature 1 . (radiopaedia.org)
  • Mucinous neoplasms of the appendix: a current comprehensive clinicopathologic and imaging review. (radiopaedia.org)
  • The final diagnosis was mucinous cystadenoma of the appendix. (vesalius.com)
  • Carcinomas of the appendix are usually mucinous adenocarcinomas with a tendency to produce peritoneal pseudomyxoma and without metastatic spread until late in the disease course. (enets.org)
  • Mucinous cystadenoma is the most common of benign neoplasms of the appendix and carcinoid is the most common type of primary malignant lesions of the appendix. (enets.org)
  • Higa E, Rosai J, Pizzimbono CA, Wise L Mucosal hyperplasia, mucinous cystadenoma, and mucinous cystadenocarcinoma of the appendix: A re-evaluation of appendiceal "mucocele. (appliedradiology.com)
Ovary3
  • Is mucinous cyst adenocarcinoma of ovary curable? (healthtap.com)
  • Vascular invasion in a mucinous cystadenocarcinoma of the ovary. (webpathology.com)
  • Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary: The Added Value of SATB2 and Biomarker Discovery Through Protein Expression Database Mining. (semanticscholar.org)
Pancreas7
  • The mouse monoclonal antibody 1D3, developed to detect a high molecular weight mucin found in a number of cystic malignancies of various organs, may be of use in differentiating primary mucinous cystadenocarcinoma of the lung from metastatic lung tumors due to mucinous cystic lesions of the uterus and pancreas, as well as those primary in the colon and stomach. (wikipedia.org)
  • Rupture of mucinous cystic neoplasms of pancreas including PMC should be remembered in acute abdomen during pregnancy. (biomedsearch.com)
  • Mucinous cystadenocarcinoma of the pancreas during pregnancy. (biomedsearch.com)
  • Mucinous cystic neoplasms (MCNs) are one of the most common types of cystic neoplasms of the pancreas that specifically occur in the pancreatic body or tail of perimenopausal women ( 1 ). (spandidos-publications.com)
  • Aim of the study: Mucinous cystadenocarcinomas (MCAC) of the pancreas are rare tumours, when localised to the pancreas alone, surgical resection is mostly associated with a favourable prognosis. (openarchives.gr)
  • 1930 Concomitant Intraductal Papillary Mucinous Neoplasms and Neuroendocrine Tumors of the Pancreas: More than just a Coincidence? (enets.org)
  • Mucinous cystic neoplasms of the pancreas occur relatively frequently and mainly affect women in the transition to menopause. (scielo.org.co)
Diagnosis2
  • Although preoperative diagnosis is difficult, urologists should consider the possibility of primary mucinous adenocarcinoma in patients with severe hydronephrosis accompanied by renal stones and chronic inflammation. (eurekamag.com)
  • Imaging cannot reliably differentiate cystadenoma from cystadenocarcinoma, but the presence of septal nodularity may favor the diagnosis of biliary cystadenocarcinoma versus a biliary cystadenoma 3,7 . (radiopaedia.org)
Malignant mucinous4
  • Moreover, mutation rates of oncogenes such as KRAS are similar among benign, borderline and malignant mucinous tumors [10]. (fortunejournals.com)
  • They can grow to relatively enormous sizes (up to 20cm) and it appears that the larger the tumour is, the more likely it will have undergone malignant change, from a benign mucinous cystadenoma to a frankly malignant mucinous cystadenocarcinoma. (eurorad.org)
  • b Borderline malignant mucinous cystadenoma and acellular pools of mucin (×10). (springermedizin.de)
  • Complete surgical resection is the only treatment that can improve long-term survival in patients with malignant mucinous cystic lesions. (scielo.org.co)
Appendiceal mucinous3
  • Indeed, the 5-year survival of appendiceal mucinous adenocarcinomas with distant metastasis is significantly better than those of non-mucinous carcinomas. (springer.com)
  • Summary The manifestation degrees of miRNAs examined were significantly modified in the appendiceal mucinous cystadenocarcinoma examples set alongside the mucinous cystadenoma. (conferencecallsworld.com)
  • According to a panel of specialist review in 2016, a new nomenclature and classification for the appendiceal mucinous neoplasms based on their histologic type and biologic behaviour has been proposed and since then the term mucinous adenocarcinoma should be reserved for the mucinous tumours that have an infiltrative invasion beyond the muscularis mucosa 1,2 . (radiopaedia.org)
Cyst1
  • Although majority of primary retroperitoneal mucinous tumors grow as a unilocular cyst [7] in contrast to ovarian mucinous tumors that usually give a multilocular appearance with numerous septations, retroperitoneal and ovarian mucinous tumors could share similar pathogenesis. (fortunejournals.com)
Epithelial4
  • Papillary cystadenocarcinoma, in turn, comprises an extremely rare lesion, accounting for 0.5% of all epithelial lesions affecting the salivary glands 2 and according to the second largest survey on cystadenocarcinomas described in the literature, the highest prevalence is also observed in the major salivary glands 3 . (bvsalud.org)
  • Mucinous cystic neoplasms of the liver and extrahepatic biliary tree have recently been re-defined by WHO as epithelial cystic tumours with ovarian-type mesenchymal stroma. (intechopen.com)
  • Currently, mucinous cystic neoplasms of the liver are defined as epithelial cystic tumours associated with ovarian-type mesenchymal stroma. (intechopen.com)
  • The gross and histologic features of such metastases overlap those of primary ovarian epithelial neoplasms such as endometrioid or mucinous adenocarcinoma. (semanticscholar.org)
Pancreatic mucinous cystadenocarcinoma2
  • An extremely rare cause of acute abdomen in pregnancy: ruptured pancreatic mucinous cystadenocarcinoma. (biomedsearch.com)
  • The prognosis of invasive pancreatic mucinous cystadenocarcinoma (MCC) is poor, and the molecular mechanism underlying its development remains unclear. (spandidos-publications.com)
Biliary cystadenoma4
  • Mucinous cystic neoplasms of the liver [ 1 ], formerly known as bile duct/biliary cystadenoma and biliary cystadenocarcinoma [ 2 ], represent an enigmatic entity, characterised by unknown origin and peculiar morphology including the presence of ovarian-type stroma. (intechopen.com)
  • MRI signal characteristics of biliary cystadenoma/cystadenocarcinoma are not specific for the disease. (medscape.com)
  • Biliary cystadenoma and cystadenocarcinoma: CT and sonographic findings. (radiopaedia.org)
  • Biliary cystadenoma and cystadenocarcinoma: clinical-imaging-pathologic correlations with emphasis on the importance of ovarian stroma. (radiopaedia.org)
Mucin1
  • An adenocarcinoma is defined as mucinous when extracellular mucin corresponds to more than 50% of the lesion. (radiopaedia.org)
Lesions2
  • In a review of 66 cystic pulmonary mucinous lesions, Gao and colleagues reported that p53 expression and a Ki-67 index exceeding 20% is characteristic of MCACL. (wikipedia.org)
  • Pulmonary Mucinous Cystadenocarcinoma Presenting as Extensive Multifocal Cystic Lesions. (amedeo.com)
Benign2
  • Primary retroperitoneal mucinous cystadenocarcinoma could arise from the pre-existing benign mucinous cystadenoma. (fortunejournals.com)
  • Amongst benign tumors, serous cystadenoma was the most frequent subtype, while for the malignant tumors serous cystadenocarcinoma was the commonest. (thefreelibrary.com)
Serous cystadenoma1
  • Pancreatic neueroendocrine tumors rarely undergo cystic changes but they are often misdiagnosed as pancreatic mucinous cystadenoma, mucinous cystadenocarcinoma, serous cystadenoma, and solid and cystic papillary tumors, or pseudocyst. (enets.org)
Mucocele2
  • Appendiceal mucocele due to mucinous cys. (cu.edu.tr)
  • 2,5 Rupture of the mucocele may result in pseudomyxoma peritonei, which is characterized by implantation of mucinous epithelium on the peritoneum and mucus accumulation within the peritoneal cavity, often leading to adhesions and intestinal obstruction. (appliedradiology.com)
Histological2
  • However, neither imaging technique is good at distinguishing between the histological types of the mucinous cystic neoplasms, unless there is frank invasion of adjacent structures or if metastatic disease is present. (eurorad.org)
  • Histological findings (H&E). a Ovarian mucinous cystadenoma (×10). (springermedizin.de)
Columnar1
  • Microscopic observation showed that the cystic walls were lined mainly by single-layered tall mucinous columnar epithelium (Fig. 2 a). (springermedizin.de)
Pseudomyxoma1
  • Pseudomyxoma peritonei' is a misnomer and is caused by dissemination of a mucinous cystadenocarcinoma within the peritoneal cavity. (bmj.com)
Case of pancreatic1
  • Clinical case of pancreatic mucinous cystic neoplasms and literature review. (scielo.org.co)
IPMN1
  • Pancreatic neuroendocrine tumors (pNETs) and intraductal papillary mucinous neoplasms (IPMN) are increasingly recognized pancreatic tumors due to advances in imaging. (enets.org)
Lung3
  • A case of primary mucinous cystadenocarcinoma of the lung is presented. (fujita-hu.ac.jp)
  • Fine needle aspiration cytology of mucinous cystadenocarcinoma of the lung - report of a case with radiographic and histologic correlation. (mesotheliomasymptoms.com)
  • The histology of the endobronchial lesion was mucinous adenocarcinoma of the lung. (archbronconeumol.org)
Cystadenomas3
  • As is the case in ovarian mucinous tumors, primary retroperitoneal mucinous tumors are divided into three categories: mucinous cystadenomas, mucinous borderline tumors, and mucinous cystadenocarcinomas. (fortunejournals.com)
  • About 25% of adnexal growths are endometriomas, 33% are mature cystic teratomas, and the rest are functional cysts or serous or mucinous cystadenomas. (news-medical.net)
  • Some biliary cystadenomas may rarely develop into a cystadenocarcinoma 9 . (radiopaedia.org)
Neuroendocrine1
  • Intraductal papillary mucinous neoplasms (IPMNs) and pancreatic neuroendocrine tumors (pNETs) are rare tumors. (enets.org)
Prognosis2
  • Primary retroperitoneal mucinous cystadenocarcinoma (PRMC) is extremely rare, and its biological behavior, pathogenesis, optimum treatments, and prognosis remain to be elucidated. (springeropen.com)
  • To enhance the knowledge of medical society on the mucinous cystic neoplasms of the liver, here we aim to summarise contemporary data on these tumours, including the current definition and classification [ 1 ], the recent molecular genetic findings [ 3 , 4 ] as well as the practical issues of clinical presentation, diagnostic approach, treatment and prognosis. (intechopen.com)
Clinical2
  • Despite the favorable clinical features, after surgical removal, was diagnosed as papillary mucinous papillary mucinous cystadenocarcinoma. (bvsalud.org)
  • Intrahepatic biliary cystadenocarcinoma: clinical analysis of 4 cases. (radiopaedia.org)
Mucinous Cystadenocarcinoma, Appendix | SpringerLink
Mucinous Cystadenocarcinoma, Appendix | SpringerLink (link.springer.com)
July-August 1999 - Volume 23 - Issue 4 : Journal of Computer Assisted Tomography
July-August 1999 - Volume 23 - Issue 4 : Journal of Computer Assisted Tomography (journals.lww.com)
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene - Full Text...
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene - Full Text... (clinicaltrials.gov)
Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary...
Carboplatin, Gemcitabine Hydrochloride, and Berzosertib in Treating Patients With Recurrent and Metastatic Ovarian, Primary... (clinicaltrials.gov)
DIT Rapid Fire Facts Flashcards by Sadaf S | Brainscape
DIT Rapid Fire Facts Flashcards by Sadaf S | Brainscape (brainscape.com)
KRT7 Gene - GeneCards | K2C7 Protein | K2C7 Antibody
KRT7 Gene - GeneCards | K2C7 Protein | K2C7 Antibody (genecards.org)
Recruiting for Clinical Trials | New Mesothelioma Treatment Studies
Recruiting for Clinical Trials | New Mesothelioma Treatment Studies (mesothelioma.com)
Laparoscopic Approach of the Left Side of the Pancreas | Cirugía Española (English Edition)
Laparoscopic Approach of the Left Side of the Pancreas | Cirugía Española (English Edition) (elsevier.es)
Haad Radiology Exam Quiz: Trivia! - ProProfs Quiz
Haad Radiology Exam Quiz: Trivia! - ProProfs Quiz (proprofs.com)
Pelvic Masses Including Ovary, Tube and Uterus
Pelvic Masses Including Ovary, Tube and Uterus (wdxcyber.com)
Pediatric Ovarian Malignancies | GLOWM
Pediatric Ovarian Malignancies | GLOWM (glowm.com)
Biliary Cystadenoma/Cystadenocarcinoma Imaging: Overview, Radiography, Computed Tomography
Biliary Cystadenoma/Cystadenocarcinoma Imaging: Overview, Radiography, Computed Tomography (emedicine.medscape.com)
Autophagy promotes malignant migration and invasion via miR‑224‑5p/BCL2 in pancreatic mucinous cystadenocarcinoma MCC1 cells
Autophagy promotes malignant migration and invasion via miR‑224‑5p/BCL2 in pancreatic mucinous cystadenocarcinoma MCC1 cells (spandidos-publications.com)
Barbara A. Centeno | Moffitt
Barbara A. Centeno | Moffitt (moffitt.org)
Pathology Outlines - Colloid (mucinous noncystic) carcinoma
Pathology Outlines - Colloid (mucinous noncystic) carcinoma (pathologyoutlines.com)
Diseases of the Peritoneum | SpringerLink
Diseases of the Peritoneum | SpringerLink (link.springer.com)
Plus it
Plus it (cebp.aacrjournals.org)
Health Library - Adventist HealthCare
Health Library - Adventist HealthCare (adventisthealthcare.com)